integrated report year ended december corporate philosophy essence contents management providing value businesses corporate culture otsukas history addressing social issues otsukas strengths ryukangodo value creation process generates originality keeping corporate philosophy otsuka values ryukangodo sweat sweat value creation model recognize way jissho actualization sozosei creativity strive otsuka recognize way materiality otsuka group supports lives people worldwide wide range innovative process discovering initiatives sustainability creative products including pharmaceuticals functional beverages functional foods core substance message president dedicated cultivating dynamic corporate culture workplaces reflect vision something message cfo healthcare company finding ways live harmony local communities natural hard work practice feature environment contributing richer healthier lives realizing better health people worldwide fluids electrolytes essential life year history future pocari sweat business strategy section positioning third mediumterm management plan jissho progress third mediumterm actualization management plan otsuka looking ahead fourth selfactualization mediumterm management plan achievement completion beyond discovery truth otsuka groups csr corporate social responsibility toward realizing sustainable society materiality society otsukas goal health people quality become indispensable contributor environment sozosei peoples health worldwide governance creativity corporate governance pursuing directors audit supervisory otsuka group aims indispensable contributor peoples health worldwide fulfilling otsuka capable board members corporate philosophy every aspect operations commitment improving peoples delivering messages outside directors health worldwide part unchanging value continue provide society operations compliance encompass two core businesses pharmaceutical business provides comprehensive health tax compliance support diagnosis treatment diseases nutraceutical business helps people risk management maintain improve daytoday health financial nonfinancial highlights nutraceuticals nutrition pharmaceuticals main data corporate information global network group structure overview main operating companies disclosure otsuka group shareholder information otsuka holdings co ltd integrated report providing value businesses otsuka group companies contributes peoples health worldwide creating innovative products two core businesses pharmaceutical business aims address unmet medical needs nutraceutical business seeks fulfill yettobeimagined needs consumers unmet medical needs diagnosis treatment providing value pharmaceutical business bringing health people worldwide total healthcare physical mental wellbeing wellbeing otsuka social wellbeing yettobeimagined needs maintaining improving daytoday health nutraceutical business state health defined constitution world health organization otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsukas history addressing social issues since founding chemical raw materials manufacturer otsuka group worked address social issues providing products help realize healthcare aligned societys expectations responding changing times business environment group continued grow contributing health three areas physical mental social wellbeing year centennial founding consistent aspirations company founders aim offer products services coming years perpetuity helping address future social needs combating tuberculosis old disease new option new face antipsychotic medications deltyba improving qol evolving cancer patients abilify tuberculosis infectious disease mankind long fought iv solutions eradicate remains serious global health issue futraful diseases central nervous system cns include numerous duty persevere others continued business disorders underlying causes diseases yet research area culmination years intravenous solutions launched subsidiary taiho pharmaceutical oral anti precisely elucidated making research development research deltyba approved one worlds first new cancer agent time medicine widely used treatments extremely challenging antipsychotic agent abilify tuberculosis drugs half century become otsukas intravenous solutions business began japan anywhere world unlike conventional anticancer agents launched otsuka pharmaceutical us first essential treatment multidrugresistant tuberculosis time futraful enabled outpatient treatment making postww ii period nutrition major issue therapeutic agent cns developed inhouse drug hospitalization unnecessary since taiho pharmaceutical nation otsuka pushed forward technological innovations discovery basis unique characteristics launched oral anticancer agents uft ts lonsurf met needs medical institutions development well received physicians patients pharmaceutical business contributed improved quality life qol cancer patients japans first plastic bottle intravenous solutions using local production expanded business countries asia seeking advance sanitary practices changes concept health social wellbeing mental wellbeing announcement third mediumterm physical wellbeing management plan nutraceutical business importance hydration solving issues becomes apparent relating irregular pocari sweat eating habits unbalanced diets supplementing nutrient inspired idea drinkable intravenous solution pocari deficiencies food sweat developed beverage could easily replenish calorie mate solutions support fluids electrolytes ions lost perspiration rd nature made progressed target creating health drink everyday womens health leveraging expertise highdensity liquid diets clinical life pocari sweat launched japan nutrition business created calorie mate provides modern times changes lifestyles eating habits cause equelle nutrition healthy consumers supports healthy eating habits people struggle maintaining balanced diets even busy modern lifestyles pioneer nutritionally careful meal planning difficult obtain sufficient equelle supports womens health beauty contains equol balanced foods japan topselling brand continues amounts many nutrients supplementing meals nature metabolite produced soy isoflavone fermented unique lead field made products enables consumers take recommended lactic acid bacteria sold dietary supplement support source intage sri nutritionally balanced food product market category cookies biscuits amounts nutrients womens health relieves symptoms physical mental cereals cakes januarydecember acquired pharmavite us launched sales japan changes experienced women older establishment major group companies otsuka seiyaku otsuka chemical otsuka warehouse otsuka pharmaceutical otsuka indonesia korea otsuka otsuka america otsuka holdings th kogyobu taiwan otsuka pharmaceutical otsuka america pharmaceutical anniversary otsuka pharmaceutical founding pharmaceutical otsuka foods taiho pharmaceutical thai otsuka stock publicly listed factory pharmaceutical otsuka pakistan otsuka pharmaceutical europe tokyo stock exchange china otsuka pharmaceutical otsuka medical devices otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsukas strengths value creation process generates originality achieve taking challenge otsuka otsuka people source strengths since otsukas establishment employees everywhere heart otsuka groups value creation process approach always looking pursued business guided enduring corporate philosophy order bring health people future order anticipate various needs healthcare aligned societys expectations worldwide determination employees developed many strengths try anticipate diversifying needs arise changing times environment ways six strengths described representative sample continue evolve people think health leveraging group strength unique wideranging businesses day making best possible use strengths employees take new challenges fulfill people extensive knowledge experience construct hypotheses combine potential order contribute better health worldwide new technologies scientific developments existing ones create new value working resolve social issues maximize value create products services enduring corporate philosophy process capture new needs emerge harness turn create new value managerial essence passed business model centered total healthcare sustainable growth otsuka group value creation process leads steady practiced throughout group enhancement corporate value also making possible us continue applying original approach challenge new healthcare needs contributing three aspects health countriesregions physical mental corporate philosophy displayed prominently offices every country business social wellbeing new value creation future health issues anticipated medical needs engage employees think act creatively without provide variety sciencebased products services health maintenance preconceived notions also support development meet specific healthcare needs times fourth industrial revolution embody unique capabilities potential community conceive products services contribute believe well engagement corporate years time three areas physical mental chemicals signs selfmedication philosophy managerial essence reflected corporate social wellbeing derivation unwellness culture brought us today build niche big data iot otsuka tomorrow global reach incorporating solutions unwavering quest originality social issues core business processes chain g iv solutions business synergy creativity chemicals nc ul tin rii tc ia ol n ai robotics inhouse drug discovery overseas companies percentage countriesregions otc pocari sweat available development projects unmet needs countriesregions created value tuberculosis drug deltyba available pursue creativity implicit corporate philosophy across entire value chain rd marketing extending global reach addressing social issues eg value creation diversifying needs ongoing challenge create innovative products services fluidelectrolyte replenishment infectious diseases differ pharma always thinking generate kind innovation countryregion depending culture customs times products services ceuticals defines otsuka targeting unmet medical needs well going forward provide products services lead nutra chemicals yettobeimagined needs consumers solutions social issues many countriesregions ceuticals ratio inhouse drug discovery projects among latephase development projects number companies engaged intravenous solutions business many december unmet needs areas defined otsuka based companies also export products neighboring countries thereby making patientsmapjp patientsmapus ssri meaningful contribution medical care countries cos otc medics new concepts solid financial foundation strong earnings ability nurture enduring brands hypotheses arising power drive sustainable growth wideranging topshare products clinical businesses consumer nutrition pharmaceutical category human resources aa rating diag medical extensive knowledge japan outside japan nostics devices experience business profit margin percentage consumers japan tried nutraceutical business sn ce iew n tt ie fic ch dn eo vlo elg oi pca ml ea nn td cosmedics cosmetics medicine pocari sweat developed brands unceasing efforts cultivating solid financial foundation strong demonstrate health value innovative products born earnings power whereby nutraceuticals intravenous solutions creative rd ability nurture brands leads sustainable generate stable earnings act base therapeutic wealth technological new concepts growth enhanced corporate value enabling us take agents driver growth fund ongoing investment scientific assets hypotheses challenge finding original approaches new healthcare needs creative new areas befitting otsuka form basis sustained investment areas create new value face copyright iqvia created based annual category totals past years including iqvia midas otsuka research categories defined changing business environment otsuka reprinted permission rating investment information inc november survey japan conducted otsuka average previous three years reference average operating profit margin sp food beverage select industry index constituents previous three years otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsukas strengths resource quality climate water social issues health people recycling governance change conservation conservation value creation process generates originality achieve vvaalluuee ccrreeaattiioonn mmooddeell rreeaalliizziinngg aa ssuuss ttaaiinnaabbllee ssoocciieettyy business strategy mediu mterm otsuka manage ment plan progress third mediumterm essence management management plan corporate culture ryukangodo jis sho sweat sozosei actual ization recognize way creativity selfactualiza tion process discovering achievement completion pursuing core substance discovery otsuka something ruth capable delivering hard work practice management resources supporting otsuka group human capital relationship manufactured capital intellectual capital financial capital natural capital social capital employees manufacturing sites research sites total assets billion japan total group companies japan japan outside japan japan outside japan outside japan outside japan locations countriesregions data companies including otsuka holdings subsidiaries affiliated companies december people environment corporate govern ance compliance risk management corporate philosophy otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report implementation sustainability initiatives high high ytilibaniatsus ot drager htiw ecnatropmi increasing aging issues nutritional needs global warming spread infectious diseases unmet medical health needs social change risk unprepared consumption production diversification impairs sustainability environmental load increase fragile reducing freshwater governance system availability presenteeism degree impact business activities nine highly important material issues indicated bold materiality otsuka group determined material issues based importance society materiality groups businesses based process described preceding material issues otsuka group determined society health people quality environment climate change resource recycling conservation water process determining material issues conservation governance determine otsuka groups material issues first compiled list social issues referencing range international guidelines frameworks including iso gri un sdgs narrowed list issues evaluating materiality social issues goals activities related sdgs terms importance taking account ability contribute solution impact business strengths issues discussed csr promotion committee approved otsuka holdings board directors meeting result material issues otsuka group determined society health people quality unmet medical contribute unmet needs promotion rd unmet health needs solutions needs environment climate change resource recycling conservation water conservation governance spread infectious eradication tuberculosis rd antituberculosis drugs oh c ffte ii cv c eit ris ser p ft r eo h e c hoo ci oun mk ac p ao h nm ylm ii ntt ge se p irr eo cm rt e ins cc hs ar r gth e r oo fu cgh ru pt r oh oo tit os nu k sa e rg vr eo su ap tt hh ee c c oo mm mm itit tt ee ee cs h r ae rp con os mib mili ti te es e n mc elu md e rsis c cu os msi pn rg ea n red g ioe nci ad l gg ro un p mhe nd air ge ec rt si inn v lvd e dp l ia nn cs sfo rr ac ns dr csr ni use tra ie os nal needs c rer ae la izt aio tin f f asy hst ee lth f fo ur l lh ifee ccd e sim sprovement drug health increasing aging issues healthy life extension au ctp ivp ito iert fn od r pa ew oa pr le en se hss e alth maintenanceimprovement mainly exercise identification social issues reference respective international guidelines nutrition etc promotion problem solving strengthening partnerships assessment social issues business activities contribute solving importance presenteeism creation corporate human resource development ho ec aie ltt hy ier people u din vep rr se ip fia cr ae td io nfor c cu relt au tir tt yhat stimulates diversity promotion determination material issues csr promotion committee society enhance employee health management viewpoint impact society otsuka group engagement approval otsuka holdings board directors meeting consumption gaining stakeholder trust sustainable procurement production pursuing sustainability product design impairs sustainability levels value chain thorough quality control establishing quality stable supply map social issues quality assurance system safety responsible promotional security activities information provision deepening communication stakeholders promotion customer centric management climate global warming fy goal reduction reduce co emissions change co emissions compared throughout value chain fy environmental load fy goal reduction reduce environmental increase simple incineration impact improving resource landfill compared fy resource efficiency environment recycling fy goal higher promotion business activities healthier content recycled aimed sustainable state planet conservation plantbased materials society earth pet bottles reducing freshwater fy goal improvement understanding water resources water availability water use efficiency risk conservation compared fy management effective use water resources fragile governance longterm improvement strengthening corporate system corporate value governance governance social change risk thorough compliance risk identification evaluation management initiatives sustainability situation productivity go due poor condition mind body despite coming work otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report materiality social issues goals fy goals fy progress society unmet medical health needs contribute unmet needs solutions promotion rd unmet needs maintained ratio rd expenses revenue pharmaceutical business areas unmet needs least three consecutive years new development projects latephase development projects advancing next phase health financial nonfinancial highlights areas unmet needs new development projects latephase development projects advancing next phase business strategy section spread infectious diseases eradication tuberculosis provide deltyba generic name delamanid cumulative total provided deltyba approximately cases cases expanded countriesregions deltyba available supply deltyba pediatric patients us national institutes health nih launched largescale clinical trial launch clinical trial new treatment regimen confirm preventive efficacy delamanid multidrugresistant tuberculosis increase access deltyba collaborating partners continued participation global health innovative technology fund ghit fund nutritional needs creation system realization create new systems reinforce existing systems realizing executed cooperation agreements prefectures promoted healthful life healthy lifestyles collaboration health fields create new concepts products keeping eye changes continued hold womens health seminar environments challenge new categories new areas womens health continued providing dietary education app sketchcook nature made supplement check th anniversary otsuka health comic library cumulative total oathas registrants approximately established new company health drink business myanmar unprepared diversification creation corporate culture instill corporate culture philosophy cumulative total participants executive human resource development stimulates creativity build systems ongoing human resource development aligned programs otsuka global academy people changes society times introduced family smile support system work interval system enhance employee engagement promote instill diversity source innovation cumulative total participants health seminars build new systems maintain comfortable working environments consumption production pursue sustainability levels companies implementing saq cumulative total companies implementing saq impairs sustainability value chain carry csr procurement held global production meetings environmental management information quality supplier briefings timescompanies commencing fy exchange meetings held global product quality meetings improved products based customer feedback carried initiatives reduce food waste environment global warming fy goal introduce renewable energy raise usage rate cofree electricity set group environmental goals climate reduction co emissions compared introduced cofree electricity change fy obtained science based targets sbt initiative certification otsuka pharmaceutical taiho pharmaceutical environmental load increase fy goal strengthen cooperation reducing simple incineration landfill standardized tracked global data waste recycling volume reduction simple incineration volume resource landfill compared fy build internal group system improving usage rate recycled recycling plantbased materials conservation fy goal higher content recycled plantbased materials pet bottles reducing freshwater availability fy goal improve water use efficiency accordance water risk carried water risk assessments using aqueduct water improvement water use efficiency unevenly distributed countryregion conducted water use questionnaires clarified issues production site conservation compared fy governance initiatives sustainability among social issues determined otsuka groups materialities selected currently regard highly important set goals related fiscal social change risk longterm improvement corporate value strengthen corporate governance raise effectiveness introduced restricted stock compensation plan build governance system capable global business development began fullscale activities global business support department response various changes strengthen oversight overseas subsidiaries build system strengthen compliance within group carried activities directors raise effectiveness board directors meeting attendance rate established global anticorruption policy global conflict interest policy unmet needs areas defined otsuka based patientsmapjp patientsmapus ssri otsuka advanced training healthy aging supporters program supports pharmacies health information hubs strong connections local communities csr procurement selfassessment questionnaire aqueduct water risk atlas water risk mapping tool developed world resources institute otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report message president otsuka group companies contribute q otsuka groups longterm vision society achieving sustained growth create provide comprehensive portfolio companies around world mainly taken otsuka products services meet specific healthcare form philanthropy needs times community factors simultaneously maintaining improving health influence needs include emergence new integral part nutraceutical business otsuka disease trends demographic trends aging continues invest research clarifies people populations rates population growth maintain healthy lifestyle thereby avoid uneven around world simultaneously factors illness fundamental demand driver nutraceutical influence ability address needs products peoples greater proactivity managing include evolution gene therapies area heath across entire lifespans includes otsuka investing artificial intelligence example women balance professional technologies becoming indispensable contributor family demands athletically minded people aiming peoples health worldwide requires us anticipate improve overall fitness stamina older societys expectations years time people seeking extended qualityoflife benefits kind contributions pharmaceutical contribution nutraceuticals also takes research business make populations continue age based approach aim create products treatments better yet preventions needed offer tangible healthsupportive benefits diseases alzheimers disease various forms areas immune function quality sleep cancer time infectious diseases special dietary needs even intangible benefits tuberculosis become even pressing global support individual lifestyles work styles given challenges extreme many hereditary time required product development must orphan diseases lack treatments otsuka construct hypotheses look years contributing research many disease future start developing products areas covid contributions group q business risks opportunities see long term changes human needs business managing overwhelmed risks landscapes largest sources risk right approach otsuka tatsuo higuchi opportunity risks management factors total healthcare company operations president representative director ceo decision making include macroeconomic encompass products services diagnosis otsuka holdings co ltd geopolitical climates physical climate treatment diseases well increasingly frequent natural disasters caused part maintenance improvement health medical cost global warming demographic changes order inflation due aging populations increasing devise optimal responses solutions must identify sophistication medical treatment serious global root causes opportunity side involves issue provider total healthcare solutions evolution product development technologies recognize developments responsibilities expansion presence new regions opportunities diverse portfolio enables us turn forging new research commercial collaborations risks opportunities focusing energies opportunities enduring corporate philosophy otsukapeople creating new products better health worldwide otsuka group companies creates innovative products fulfill universal human desire healthy q otsuka need improve corporate value achieving sustainable growth core management approach leverage strengths capabilities described keeping corporate philosophy long three categories society health people quality following pages enable us otsuka also standing esginformed commitment contributing environment climate change resource contributing advancing sustainable society stand juncture everlarger human health set forth csr mission recycling conservation water conservation social change philosophy serves solid foundation guiding us amidst trends announced third mediumterm management plan governance within category carry tides times take new challenges opportunities may csr mission defines material issues initiatives related themes otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report society focus human resources order subsequent pollution issued otsuka group leverage together advantages achieve sustainable growth continuous improvement plastic policy defines goals achievement wideranging businessessuch diverse wealth capabilities individuals teams organizations undertaking groupwide initiatives technological scientific assetsto create novel required addition management principles governance built framework ideas ultimately new value corporate culture recognize employee growth four directors outside directors way otsuka group able help society important management issue end otsuka three four audit supervisory board members achieve sustainable growth increase corporate value holdings launched executive human resource outside auditors april outside medium long term ultimately make development programs otsuka global academy directors yukio matsutani extensive vision realityto become indispensable foster human resources capable driving future experience deep insights medical contributor peoples health worldwide growth three programs offered group employees welfare field ko sekiguchi extensive senior leadership program middle leadership management experience highlevel expertise program designed nurture management pharmaceutical industry yoshihisa aoki q essential otsukas development candidates global leadership program extensive management experience deep expertise launched fostering global managerial food industry starting year mayo order better recognize stand companies solid philosophical foundation cadre comprised employees around world mita highly knowledgeable regarding finance strive must continually question strongest turbulent times ability group company also actively involved markets diverse experience expertise perspectives strategy culture capabilities embrace change continually take new human resource development instance otsuka outside directors complements knowledge strategy closely tied corporate philosophy challenges individual leaders acting pharmaceutical operated wing voluntary skills nine inside directors together guides thinking alone generations employees leadership study group since participants form effective governance body capable foundation business strategy inspired founders identify internal external issues work vigorous discussion expression determination constantly take upholding strategy culture takes teams discuss potential solutions formulating sheer number companies otsuka new challenges generate innovation formidable capabilities individual must proposal consideration taiho pharmaceutical group means effectively managing subsidiaries culture best defined words constantly review capable global one academy established japan around world necessitates founders ryukangodo jissho sozosei swiftly address deficiencies addition individual growth believe different approach singlepurpose company diversity vital variety innate qualities management requires oversight detailed individuals bring teams important us knowledge companys business actively welcome people nationalities races also working solidify management platform ages genders abilities belief breaking underpinning global operations ryukangodo jissho sozosei barriers inclusion key sparking standardization better efficiencies including process discovering selfactualization innovation furthering globalization expansion shared services optimization pursuing core substance something achievement completion otsuka capable environment initiatives focus procurement addition strengthening hard work discovery delivering practice truth sustainability throughout supply chain internal control functions ensure disciplined steadily implementing various measures management enhancing management functions included introduction cofree impact amplifies across organization electricity cogeneration systems moreover boost corporate value response pressing issue plastic usage q ensure engagement otsukas philosophy approach among employees around world q describe otsuka groups value creation model contribution sustainable society believe effective way instill global brand sales exceeding one billion us dollars philosophy share stories successes concrete example like inspires better guided corporate philosophy otsukapeople unwavering quest originality global reach failures along way stories words understanding otsukas innovation contributes creating new products better health worldwide incorporating solutions social issues core communication grounded experience peoples health generating engagement essence managementryukangodo business processes ability nurture enduring fact philosophies approaches otsukas philosophy culture successes jissho sozoseiwe seek demonstrate brands solid financial foundation strong shared properly abstract alone must brought us today build unique capabilities achieve unique potential earnings power drive sustainable growth accompanied concrete examples take instance otsuka tomorrow thereby contributing realization sustainable also value creation process enables otsuka development samscajinarcjynarque otsuka celebrate th anniversary society stable growth things companies first firstinthe world therapy adpkd took ideal opportunity group companies six strengths underlie success enduring seek anticipate emerging needs broad ten years conduct phase iii trials japan around world deepen employee corporate philosophy managerial essence consumer patient populations use us since grown next understanding otsukas philosophy approach passed practiced throughout group products well needs arising evolving blockbuster product following abilify overall prepare embark another century success business model centered total healthcare environments around world business brand name adpkd treatment multiple regions outside japan brand name adpkd treatment us autosomal dominant polycystic kidney disease otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report message cfo targeting sustainable growth maximizing existing business value creating new value returns excess cost capital increased corporate value consider growth potential future earning power capital efficiency enhance cash improving quality profit roic wacc lm onp gr tv ee rm roic medium reinvestment flow generation capital cash flow allocation cash flow generation carry disciplined growth investments consider cost secure cash returns excess cost capital capital secure funds shareholder returns efficiency optimal achieve organic growth make investments mainstay pharmaceutical business growth synergy existing management resource allocation nutraceutical products profit operating investments assets generate greater value brands cagr cash flows reinvestment create new value em ffip cr io ev ne c yworking capital ccc expc ea np dit ia tul increase investment efficiency divest idle assets reduction nonoperating assets dividends maintain basic policy stable shareholder dividends take debt capacity account debt financing returns share buybacks p rero tuv rid ne da ed pd eit nio dn ina gl oh na r pe rh oo fil td ger r owth return invested capital weighted average cost capital optimal capital structure cash conversion cycle control invested capital consideration financial soundness debt capacity financial leverage appropriate maintaining aa rating business management corporatewide financial framework conducive improving awareness capital cost mediumtolongterm corporate value third mediumterm management plan positioned securing cash returns excess cost capital period adopting business management corporate achieving true improvement corporate value means wide awareness capital cost strategy maximizing simply generating profit must enhance free cash flow existing business value creating new value generation therefore focus strongly improving promote approach throughout group target profit structure sustainable growth secure operating cash flows organic already consider cost capital deciding business growth reinvest growth areas distribute returns individual investments recognizing impairment losses shareholders maintaining appropriate level included business management corporatewide financial leverage furthermore establish framework awareness capital cost third mediumterm achieves returns reinvested capital excess management plan instill broad awareness cost cost capital drive profit growth turn capital throughout group relates individual enable us make growth investments enhance investments lead sustainable shareholder returns effective cash flow generation invested capital operating approach greater investment efficiency cash flow allocation policy second mediumterm balance allocation cash flows operating liabilities management plan pursued policy working capital etc invested capital prioritizing growth investments aimed generating ongoing active strategic investment using revenues financing approach increases mediumtolongterm returns excess cost growing global sales abilify operating assets capital delivering stable shareholder returns working capital financing succeeded diversifying revenue fixed assets etc interestbearing debt growth investments consider investments structure furthermore given looming borrowings bonds synergy existing management assets generate greater value cost debt patent expirations major management pharmaceutical business main investments interest payments issue executed diversification aimed enhancing products pipeline psychiatry focus restructuring revenue base investments neurology oncology cardiovascular renal areas shareholders equity perspective income statement nutraceutical business actively invest new nonoperating assets plan strengthen cost equity businesses meet societys future needs expected returns investment driver mediumtolong basic policy shareholder returns maintain term growth period third stable dividends emphasizing continuity mediumterm management plan beyond returns excess stability dividends consider additional shareholder optimal capital structure cost capital require us look returns depending profit growth applying comprehensive revenues income statement approach securing sufficient cash returns pursue adopt pronounced groupwide focus growth investments solid financial standing optimal increased mediumtolongterm corporate value balance sheet management capital structure creditors investors yuko makino executive director cfo otsuka holdings co ltd applying roic maximize investment efficiency capital structure optimization policy groupwide target least cost considering optimal capital structure basis capital hand contributing society use debt capacity level needed maintain currentaa ongoing innovation important us investments rating taking account factors required level include certain amount risk aligned groups shareholders equity given credit rating business risks corporate philosophy conducive sustainable growth well rate return expected investors continue take challenges time appropriately control scale implement stance believe comprehensive invested capital accordance debt capacity groupwide financial framework essential must based maintain financial discipline growth investments steady cash flow generation existing assets measures include issuing bonds commercial paper tax policy borrowing financial institutions necessary multinational enterprise otsuka group recognizes appropriate payment taxes adherence applicable laws regulations country region contributes local economies among increased calls tax transparency worldwide committed making improvements regard accordance otsuka group global code business ethics otsuka group works ensure appropriate payment taxes principle compliance shared employees including departments outside purview cfo moreover strive build constructive relationships relevant tax authorities maintaining providing reliable data accordance tax compliance policy see otsuka group implement effective management strengthen governance build constructive positive relationships respective tax authorities fulfill tax obligations countries regions otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report realizing better health worldwide feature fluids electrolytes essential life year history future pocari sweat history raising awareness heat disorders importance replenishing fluids electrolytes founded chemical raw material manufacturer electrolyte replenishment various aspects life otsuka group launched intravenous brings us present day pathology heat solutions business leveraging expertise cultivated disorders well known early days intravenous solutions business developed concept supplying electrolytes together pocari sweat beverage replenishes bodys fluids countermeasure widely understood fluids electrolytes important maintaining recognized throughout society pocari sweat become improving daytoday physical health later popular staple kinds situations people participated japan amateur sports association sweat including sports commuting outdoor work japan sport association jspo study group bath waking today continue promote prevention heat disorders sports activities began awareness importance replenishing fluids fullfledged activities raise awareness heat disorders electrolytes various contexts including childrens sports prevention since used scientific activities occupational safety hygiene hydration evidence raise awareness importance fluid elderly launched first overseas cumulative cumulative cumulative cumulative th japan market entry units sold units sold units sold units sold anniversary billion billion billion billion supplying quality fluids electrolytes people around world one unit equals ml units sold includes overseas sales began cooperation received best communicator japan amateur sports began cosponsoring production top runner award association study group guidebook heat heatstroke prevention prevention heat disorders disorder prevention based cosponsored production communication project sports activities guidelines prevention heat disorders prevention hitosuzumi awards japan sport association jspo heat disorders everyday life website npo weather caster ver published japan network society biometeorology began cosponsoring jspo heat disorder prevention pocari sweat health beverage awareness activities participated reprinting easily replenishes body fluids cosponsored production began live seminar ministry environments electrolytes lost due perspiration guidebook prevention lecture industrial physicians environmental health manual people sweat regulate heat disorder sports public health nurses nurses heat disorders body temperature lose electrolytes activities first edition commenced activities nutritionists health public health safety staff working business along fluids drinking water may centers across japan raise offices japan upset balance fluids heat disorder awareness electrolytes negatively affect among seniors physical condition performance proper hydration necessary beverage conducted lectures similar fluids already present hydration human body pocari sweat enables members junior sports clubs efficient fluid replenishment nationwide part sports activities campaign otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsuka pharmaceuticals saga nutraceuticals research institute gathers various kinds evidence clinical trials replenishment fluids electrolytes various conditions leveraging expertise research heat disorders launched pocari sweat ice slurry developed product using proprietary technology creating formulation freezes form ice slurry solid particles dispersed liquid known high cooling properties drinkable ice efficiently cools body core offers people new option combating heat disorders active hot environments otsuka pharmaceutical ion supply drink research lab future world pocari sweat aims create global warming major worldwide impact climate natural environment well peoples lives global warming continue many billion people could risk heat disorders every year year also estimated due expansion habitats conducive propagation organisms carry tropical diseases including zika fever dengue fever number people risk infection could increase million meanwhile importance proper methods fluid electrolyte present replenishment first aid heat disorders tropical pocari sweat continues create new value disease infection yet become globally recognized explore identify underlying issues country consider solutions convey scientific grounds situations body becomes dehydrated encourage consumers try pocari sweat various limited particular time place simple measures contribute health otsuka pharmaceuticals marketing pocari sweat people worldwide includes activities raise awareness importance fluids electrolytes essential life vision hydration countriesregions around world use enduring spirit inquiry ability pocari sweat continues create new valuemeeting flexibly address needs diversifying society make challenge changes environment peoples pocari sweat health beverage like values social diversification pocari around world many people sweat continues closely intertwined peoples difficulty maintaining health lack access lives uncover address underlying issues quality source hydration pocari sweat aims sciencebased solution universal needs generates change world industry leader value leads better health better lifestyles contributing solving social issues daniel li et al environ res lett sales countriesregions production countriesregions sites replenishing fluids electrolytes lost perspiration around world two years launch japan pocari sweat made overseas debut present httpswwwotsukacojpennutraceuticalaboutrehydrationresearchlab sold countriesregions otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report business strategy section positioning third mediumterm management plan linking investments results across entire value chain investing anticipation changes issues five ten years future advance global market working steadily generate results investments unique total healthcare company fiveyear growth phase existing business value maximization new value creation performance target business profit cagr organic growth mainstay products brands pharmaceutical nutraceutical businesses actively invest rd continue creating new drugs drive revenue beyond next mediumterm management plan business strategy existing business value maximization new value creation strategic initiatives mainstay products brands accelerate growth strengthen strategic initiatives growth drivers global products pharmaceutical business major brands nurture brands nutraceutical business initiatives nextgeneration businesses products launch nurture new drivers sustainable growth pharmaceutical nutraceutical businesses business profit cagr revenue business profit rd expenses alltime highs third mediumterm management plan targets roe higher rd ratio pharmaceutical business higher versus revenue social issues relating strategies kpis social issue strategic theme kpis third mediumterm management plan existing business value revenue global products increase billion maximization revenue new products increase billion address unmet needs psychiatry neurology area projects filed regulatory approval first mediumterm second mediumterm third mediumterm challenge new frontiers management plan management plan management plan rexulti avp agitation associated dementia otsuka alzheimers type rexulti ptsd centanafadine adhd pharmaceutical unmet medical fremanezumab migraine business health needs create firstinclass products oncology area projects filed regulatory approval tas gastrointestinal stromal tumor tbi synovial sarcoma generate innovation tas intrahepatic cholangiocarcinoma creative diverse research platforms create firstinclass products cardiovascular renal area projects filed regulatory approval vadadustat renal anemia ultrasoundbased renal denervation system refractory hypertension revenue major brands increase billion challenge new categories revenue nurture brands increase billion nutraceutical new areas pocari sweat overseas revenue cagr nutritional needs business daiya foods revenue cagr continuous high profit fiscal business profit margin nutraceutical business structure seitivitca tnemtsevni rof yaw eht evap hcraeser generating innovation creative diverse research platforms acquired astex pharmaceuticalsb c acquired visterra including rights antibody platform technology established taiho innovations acquired tsukuba research institute kidney diseaserelated pipelinec executed joint research agreement phoremostc banyu pharmaceutical msdb c established taiho ventures executed comprehensive cooperation agreement japan kidney association adpkd business agreement commercialization basic research field renal science tnempoleved acquired avanir pharmaceuticals acquired neurovance including rights centanafadine e w e thx ei ee vah c e ubnu l tt sue pe hnd mn ed aa e adb n eg tcl k aid hb ni ona r dl e ot h x nl e u ali c ra l oc kn ln eoic tse g nyaa g rg ae r n sae td u c b tce ui ln l rnit ef cy ia n l l e rei x k c c cc ce q q qe e ec u u un b pu tr r rt ae oe e ee rt dd h av r dn e n e e erjf c va rr ay ee p gn lm e r oot n u npa sece tv e es z e fd nu rcl oo acm mp l aa l nm b ade rf n cr ua sa r n k b ed ioe iv sna ca igl eep ns rh ca ga eg hr sm r te sa e ic nme au ent si itc f fol oi rn r v aau nds atr di ue es n oaj sta p nwa ein th e c f e tr ax slk c oi ie qci hamkcn u b ou g l art po ee r hr ho dd c aeuan da rd md e c si vh ag te e r civa alt eoe al ul l p eloe tgmt ipn r ciem c aeg ln c ee ot ms lat l saei n tan bn edn xot n ra p ae pc ha tw p r aiokm r e n r ai nnee c r g ea tc h us ra e tig il ci ohz ana ls st c ao l nn ga mg b ar se r ee n bn ia tt h sw ai h executed joint development exclusive sales agreement takara bio genemodified cell therapyc selas strengthening infrastructure group collaborations executed license agreement development commercialization oncology area servier lonsurf europe regionsa transfer north american marketing rights astex products executed copromotion agreement msd keytruda japan taiho oncologyb acquired jasmine strengthening products pipeline business acquired nutrition sant sas ns acquired foodstate entered natural foodbased supplement operations japan business acquired biocentury started copromotion lcz japan acquired bc bio taking challenges new regions acquired daiya foods established new health beverage subsidiary myanmar established new health beverage subsidiary mexico noitcudorp global products driving groups growth maximize value global productsabilify maintena rexulti samscajinarcjynarque lonsurf continued invest growth including signing joint development sales agreement lundbeck abilify maintena rexulti establishing inhouse development sales system us oncology business signing european licensing contract servier lonsurf result products driving groups growth b accelerating collaborations among otsuka pharmaceutical taiho pharmaceutical astex pharmaceuticals sharing proprietary cuttingedge technologies cultivated operating company c diversification drug discovery modalities focus generating innovation creative diverse research platforms plan diversify drug discovery modalities strengthen inhouse drug discovery platforms mainly collaborating acquiring organizations innovative highly original drug discovery technologies second mediumterm management plan third mediumterm management plan fourth mediumterm management plan beyond aim become topclass player expand new core psychiatry neurology area therapeutic areas cardiovascular renal area plan launch treatment agitation plan launch fremanezumab treatment migraines accelerate global plan launch centanafadine development treatment adhd oncology area plan launch ultrasoundbased renal denervation system launched abilify maintena rexulti japan us diversification drug discovery modalitiesc europea accelerating collaborations among otsuka pharmaceutical taiho pharmaceutical astex pharmaceuticalsb launched jynarque us nutraceutical business jinarc europe grow revenue added indications samsca japana billion achieve business profit launched lonsurf japan margin higher us europea established new factory pocari cw omea pt le tn e dc h ai n na ew production base established new factory ns glutenfree products e ms ata nb ul fi ash cte ud r nh ge ft ao ck ilu yhima mima factory new pharmaceutical nature made us agreement terminated otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report progress third mediumterm management plan rexulti brexpiprazole atypical antipsychotic overview fiscal marketed adjuvant treatment major depressive disorder treatment schizophrenia us drug fiscal first year third mediumterm management plan steadily executed priority measures highly evaluated efficacy safety new treatment option diseases japan drug marketed aimed maximizing existing business value result revenue billion yen increase treatment schizophrenia prescriptions grown significantly following lifting restrictions maximum previous year indicating solid growth furthermore business profit billion yen substantial increase prescription period may europe sales began april previous year outperforming third mediumterm management plan forecast year present several clinical trials way aim contributing treating unmet needs billion psychiatry neurology area third mediumterm management plan progress date announced may samscajinarcjynarque global use adpkd treatment e e e cagr tolvaptan vreceptor antagonist samsca highly evaluated various guidelines japan revenue prescriptions increasing treatment business profit cardiac edema hepatic edema prescriptions rd expenses treatment intractable disease adpkd increasing launched contributed rd expenses due promotion proper use guidelines approx approx patients countries disease awareness activities business profit may jynarque launched us contributed approx patients roe higher higher treatment adpkd efforts raise disease awareness make clinical trial data available helped spread pharmaceutical business revenue plan global products recognition disease drug resulting estimated number adpkd patients new products steady increase prescriptions europe also jinarc us europe japan third mediumterm management plan calls us sold approx countries number patients march inhouse survey billion global products new products maximize existing business value create new value receiving treatment drug increase challenge new frontiers otsuka e billion lonsurf generate innovation creative diverse research platforms take advantage strategic framework b il li n trifluridinetipiracil anticancer agent position global productsabilify maintena lonsurf growing treatment option advanced colorectal cancer help enhanced promotion activities lonsurf rexulti samscajinarcjynarque lonsurfas growth ap p ro x also received marketing authorization additional indication previously treated metastatic gastric cancer us billion drivers accelerate growth targeting billion february japan august europe september clinical studies currently ongoing yen revenue increase billion yen back planned business partners academia maximize value lonsurf new products scheduled launched current aa e e e e e e e e e mediumterm management plan treatment line regimen countryregion development status third mediumterm management plan fourth mediumterm management plan study combination bevacizumab patients firstline europe phase iii progress global products billion colorectal candidates intensive therapy solstice study cancer global products made smooth progress fi rs ec va el n u e yearonyear achie rav te ement ref vis ec na ul e p la n secondline study combination bevacizumab specified clinical study japan phase iiiii overseas expanding regions adding indications abilify maintena secondline gastric cancer study combination ramucirumab japan phase ii revenue fiscal rose thirdline rexulti previous year outperforming plan targets trial sponsored servier march samscajinarcjynarque making considerable contribution growth lonsurf consolidated performance total abilify maintena initiatives maximize value global products aripiprazole antipsychotic longacting injectable atypical antipsychotic longacting injectables market north american prescription pharmaceutical business contributed impressive start third mediumterm management plan global treatment schizophrenia increased us million awareness drugs efficacy claims convenient c g r continued see strong revenue growth across cns nephrology franchises established products like rexulti abilify maintena newest jynarque continued dosage formulation following us approval additional indication treatment bipolar disorder perform well exceeded sales forecasts prescriptions increasing september also kabir nath speaks efficacy clinical value products bringing target patients healthcare professionals also direct result hard work filed additional indication bipolar disorder market share president japan ceo otsuka dedication otsuka people across organization north america whole leadership team north american pharmaceutical business committed global market atypical antipsychotic longacting pharmaceutical injectables continues grow address issue business maximizing value entire portfolio global products concurrently seek new business opportunities drive future growth ensure continue operate medication adherence schizophrenia bipolar position strength innovation disorder continue contribute patients around us left others left abilify maintena global share right world aim achieve global market share source otsuka lundbeck johnson johnson alkermes reports abilify maintena otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report nutraceutical business revenue plan major brands nurture brands nature made pharmavite leading company us supplement selfmedication increasingly prevalent us third mediumterm management plan calls revenue billion major brands nurture brands industry nature made supplement brand recent years related demand continued increase growth billion yen major brandspocari e billion pharmavite develops markets products free driven factors include medical cost inflation us sweat nature made nsand billion yen flavorings colorings preservatives lineup supplement market continues grow cagr nurture brandsbodymaint equelle daiya approx billion highquality supplements key items aim turn nature made billionyen brand furthermore working maintain highprofit billion verified meeting strict quality criteria set united developing products incorporate cuttingedge science structure capable sustained business profit margin states pharmacopeia usp nature made leading taking challenges new categories higher creating new product concepts choice us pharmacists nine product categories anticipation changes business landscapes expanding new categories new regions aa e e e e e e e e e third mediumterm management plan fourth mediumterm management plan us retail multi leading sales share vitamin sales choice japan us business profit plan pharmacists third mediumterm management plan billion business profit left new products global operations new businesses business profit margin based total us retail sales aggregate data reported scantrack service supplement vitamin category week period ended december information resources inc business profit margin intage sri health food multivitamin market cumulative market share brand januarydecember maintain higher us news world report pharmacy times survey product categories letter vitamins ae coenzyme q omegafish oil flax seed oil herbal supplements mood health supplements diabetic multivitamins cholesterol management natural garlic supplements build resilient business foundation nurture brands second mediumterm management plan major brands review management assets nutrition sant ns underpin value chain organic food market europe grown recent standard auditing food manufactures conducts e e years healthconscious consumers demand safer production concern environment high trustworthy foods trends freefrom level quality management ns built new foods alternative products attracting attention factory glutenfree products france strengthened progress major brands millennial generation fiscal european development freefrom products meet evolving pocari sweat meatfree food market worth approximately billion consumer needs overseas mainly asia sales volume pocari sweat furthermore given higher levels health consciousness us dollars grown rapidly past five years beverage replenishing fluids electrolytes strengthening global sales structure expand cagr glutenfree food market increasing due awareness activities tailored new regions expect growth demand worth around billion us dollars expanding characteristics needs region cagr health beverages cagr asiapacific sports beverage market future aim grow pocari sweat ns health nutritional food company provides period intend outpace recent market billionyen brand enhancing brand strength health foods products countries growth forecasting cagr overseas revenue original marketing thoroughly communicates around world centered europe pocari sweat period third medium product concept factories ns obtained iso iso term management plan well ifs food standard certification international sports beverage market asiapacific euromonitor international uk retail value rsp us million pocari sweat sports beverage market overseas revenue plan cagr cagr e e china indonesia thailand philippines vietnam hong kong myanmar euromonitor international uk excluding japan otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report social issues targeted nutraceutical business today pressing social issues include extended healthy life expectancy declining birthrates aging progress nurture brands populations soaring medical costs otsuka group engages product development bodymaint awareness activities aimed solving variety social health issues bodymaint commercialized based research social issues targeted otsuka conducted otsuka pharmaceutical themes intestines nutrition exercise nutrition irregular unbalanced diets focusing health management athletes exposed risks seemingly abundance food nutritional food use sports related intense training developed bodymaint jelly developed world diversification daily routines time breakfast meals work study conditioning food support many increase singleperson households contribute eating also kept disaster provision athletes sports trainers main ingredients include lactic alone skipped meals unbalanced diets lead intage sri nutritionally balanced food product market category cookies biscuits acid bacteria b proprietary ingredient well bcaa poor physical mental wellbeing otsuka group cereals cakes januarydecember tackling various social issues related nutrition arginine whey protein addition developed plantderived lactic acid bacteria b developing nutritional products implementing dietary bodymaint drink conditioning beverage containing lactic acid bacteria b plantderived lactic acid bacteria education activities isolated fermentation type tea leaf traditionally lactic acid bacteria b help replenish fluids consumed northern thailand isolated sanae okada leveraging expertise concentrated liquid diets electrolytes support proper hydration bodymaint professor emeritus tokyo university agriculture clinical nutrition business created calorie mate efficacy confirmed otsuka pharmaceutical drink expands value product line supporting provides nutrition general consumers supports j gen appl microbiol health management consumers healthy dietary life busy modern lifestyles pioneer nutritionally balanced foods japan topselling brand continues lead field compact equelle long shelf life calorie mate convenient equelle originated research conducted otsuka pharmaceuticals saga nutraceuticals research institute female hormone estrogen womens health womens health research theme equelle contains equol sold japan us food women experience mental physical changes product supports womens health beauty time equol throughout lives effects rapid hormonal changes felt women aging brings physical mental changes japan deployed dedicated staff expert knowledge equol particular impact social life equol ingredient produced daidzein soybean otsuka group identified womens health one womens health nationwide cooperation isoflavone metabolized intestinal bacteria one aspect priority areas nutraceutical business physicians pharmacists healthcare professionals otsuka pharmaceuticals many years soybean research disseminating information promote better understanding focus properties equol saga nutraceuticals research convey importance personal care women institute succeeded isolating lactococcus strain physical changes women developing related products experiencing physical mental changes among lactic acid bacteria produces equol publicize progress otsuka pharmaceuticals saga nutraceuticals research results variety research continue leader global activities aimed maintaining improving health research field institute conducts research total health maintenance women older including research women enhancing quality life symptoms menopause bone skin issues blood vessel health continues generate evidence active daiya ingredients addition experts womens health carry daiya foods develops manufactures sells highquality us plantbased alternatives market continues activities across japan spread accurate understanding creative plantbased food products cheese grow daiya foods expanding sales channels mental physical changes experienced women related health issues well solutions issues alternatives yogurt alternatives dressings desserts product lineup mainly area cheese alternatives brand daiya enjoyed vegetarians people core product third mediumterm food allergies also healthconscious management plan plan achieve revenue cagr millennial generation environmental issues given global warming major social issue public soyjoy soysh soycarat soybeans directly consumed attention focused co emissions food production people around world account mere total us plantbased part realizing carbonfree society plantbased soybean production beef one source protein alternative food market foods daiya foods develops manufactures sells produce kilogram beef said take kilograms low carbon footprint reduce environmental load grain soybeans data suggesting others daiya foods sustainable daiya foods founded production soybeans requires onefiftieth water revenue plan belief plantbased living better peoples health onetwentieth amount energy needed produce milk cagr better planet range plantbased foods volume beef based concept soylution us resonates many people category leader soy solution otsuka pharmaceutical provides solutions dairy billion evolving highgrowth company human health environmental issues yearonyear soybeans part japans traditional food culture range soy products contain quality dietary proteins referred meat meat fields focusing high nutritional value potential soybeans otsuka pharmaceutical pbfacommissioned data nielsen developed commercialized soyderived nutritional weeks us dollar sales ending december ice cream yogurt cheese creamer butter dressing foods three brands inhouse research center otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report initiatives pharmaceutical business looking ahead fourth mediumterm management plan opportunities risks psychiatry neurology total healthcare company otsuka group conducts activities related diagnosis medication aiming become topclass global player psychiatry neurology area also contribute maintaining improving health healthy people medical cost inflation due aging highpotential pipeline product portfolio populations increasing sophistication medical treatment serious issue japan rest world particular pose risk pharmaceutical business however perspective nutraceutical psychiatric diseases schizophrenia bipolar disorder highpotential pipeline product lineup business regard increased awareness selfmedication prevention daily health opportunity major depressive disorder develop age aim become topclass global player area affect persons social life career studies moreover aiming become concerns growing increasing frequency topclass global player pharmaceutical business alzheimersrelated dementia populations worldwide psychiatry neurology area continue age diseases affect patients providing total healthcare solutions diagnosis treatment global operations oncology business quality life also place strain family members highpotential pipeline product lineup global rd marketing assets psychiatry neurology management personnel diversifying businesses caregivers well healthcare economy p str r ae e ba se l e na c pn e rd oi nt fih tte h neca tor hd n ei co iv nloa trs g ac yu v eala nrr e aa u n snd ojr ae lupn taa ionl na sr e bsa usintessrength patent expiration mainstay produc wts eakness w tr hhe ics h sil l b et cia f uay sc ep ty r hyc e h irria e ct ar ti umc een sn n n h de u mvr eo e l co e hg ai c ntoa isl mbd ei ss ee asa rt es ae b ns l h fr e u fa reb mil aif nc ee zn ut mr mne ax n bfu hl dp lc n l ex iax ix lons gol au ct pi n yn cg h inb j au tes rci cn ae dbs ils e es sl ea si avp understood makes discovery new drugs neurological diseases advances science technology progress basic research global drug price control policies promotion generic drug use rexulti related diseases due medical cost inflation extremely difficult otsuka group entered psychiatry promotion personalized medicine intensifying competition core areas neurology area continued take revenues psychiatry neurology area illustrative diagram restrictions sales promotion activities due stricter regulations challenge new drug discovery goal nd mtm plan rd mtm plan th mtm plan pportunity hreat contributing medical needs agitation associated dementia alzheimers type nutraceutical business estimated approximately million people us alzheimers disease thought large number patients exhibit form behavioral disorder agitation excessive motor activity verbal physical aggression kind disorder places burden patients caregivers impacting quality life otsuka group aims market worlds first treatment creative products marketing backed scientific evidence management personnel diversifying businesses agitation associated dementia alzheimers type clinical trials way two drugs different mechanisms action ability nurture brands cultural differences regarding raw materials taste preferences brexpiprazole rexulti avp overseas businesses incorporate solutions social issues drdecision resources llc rights reserved reproduction distribution transmission publication prohibited reprinted permission core business processes w steady earnings power trength eakness march pipeline features indication countryregion development status rising consumer awareness selfmedication prevention daily sluggish overall beverage market due unseasonal weather aripiprazole health tandem medical cost inflation intensification competition core areas due entry new longacting injectable dopamine partial agonist bipolar disorder japan filed diversification diet competitors major depressive disorder japaneuropechina phase iii pportunity hreat agitation associated dementia japanuseurope phase iii alzheimers type brexpiprazole dopamine partial agonist posttraumatic stress disorder us phase iii approach issues borderline personality disorder us phase ii recent years taiho pharmaceutical pioneer oral oncology products schizophrenia longacting injectable us phase japan actively promoting globalization mainly serotonin norepinephrine dopamine global operations establishing marketing structure us expanding sales opc reuptake inhibitor attention deficit hyperactivity disorder us phase ii networks regions addition group companies including otsuka maximizing business value oncology business pharmaceutical astex pharmaceuticals taiho pharmaceutical combining group strengths agitation associated dementia useurope phase iii combining assets strengthen groupwide global operations well alzheimers type promoting strategic alliances external partners nmda receptor antagonist serotonin negative symptoms schizophrenia us phase iiiii avp norepinephrine reuptake inhibitor sigma management personnel otsuka holdings plans implements executive human resource receptor agonist traumatic brain injury us phase ii development programs collaborates external organizations train diversifying managers capable leading next generation addition individual people intermittent explosive disorder us phase ii businesses group companies vigorously promoting human resource development centanafadine norepinephrine dopamine serotonin attention deficit hyperactivity disorder us phase iii reuptake inhibitor achieve tas pgd synthase inhibitor duchenne muscular dystrophy japan phase ii based unique diverse businesses continue create intensifying competition otsuka core areas new value taking challenges applying original approach fremanezumab anticgrp antibody migraine japan phase iiiii addresses health needs people always looking future taking challenge opc epilepsy us phase otsuka development project unmet needs area defined otsuka based data patientsmap project advanced fiscal otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report oncology cardiovascular renal system maximizing business value combining group strengths creating firstinclass products new drug discovery technologies medical devices taiho pharmaceutical engages drug discovery leveraging meanwhile centering external collaborations otsuka cardiovascular renal area addition pharmaceutical areas advancing development longstanding proprietary platform focused biochemical pharmaceutical taking challenge establishing strengthening proprietary drug discovery platforms unique medical devices drawing innovative modulation well drug discovery based research therapies focus future includes creating also plan actively make growth investments examples technology strengths drugs clinical research platform newly established cysteinomix synergies new modalities areas gene included business alliance akebia examples include device ultrasound renal denervation kinase target drug discovery furthermore modified cell therapies oncolytic virus therapies therapeutics vadadustat acquisition treatment peripheral artery stent system aim collaboration relation astex pharmaceuticals fragment individual group companies combining visterra company renal diseaserelated pipeline create firstinclass products leveraging new drug based drug discovery technology taiho pharmaceutical drug discovery technologies assets bolster global also strive find solutions unmet needs non discovery technologies medical devices continues discover new molecular targeting drugs operations enhance business value march development pipeline features indication countryregion status strengths drug discovery taiho pharmaceutical syndrome inappropriate antidiuretic specialty pharmaceutical company oncology area taiho pharmaceutical utilizing tolvaptan vreceptor antagonist hormone secretion japan filed proprietary drug discovery platforms developing highlyeffective novel anticancer agents contribute diversification cancer treatment addition developing enhancing opc vreceptor antagonist cardiac edema japan phase iii platform technologies drug discovery accelerating rd complementing vadadustat hifprolyl hydroxylase inhibitor renal anemia useurope phase iii proprietary technologies collaborations research organizations outside project advanced fiscal japan furthermore corporate venture capital built proprietary network gives us access creative innovative technologies drug discovery seeds outside teruhiro utsugi company research development promising new drugs taiho pharmaceutical managing director taiho pharmaceutical contribute society enriched smiles pursue realization sustainable society initiatives nutraceutical business two research institutes nutraceutical business pharmaceutical business goal develop provide strengths drug discovery astex pharmaceuticals investigate themes nutrition exercise world creative products maintain improve established world leader fragmentbased drug discovery astex celebrated th original viewpoints utilize expertise honed peoples health backed scientific evidence anniversary time created broad portfolio programs oncology cns successful track record strategic alliances pharmaceutical collaborators saga nutraceuticals resulting two approved anticancer agents within last three years innovative culture collaborative spirit continued flourish part otsuka group research institute established new collaborations developed technology hope result many new product approvals future harren jhoti since establishment japans first private ceo research institute clinical exercise nutrition astex pharmaceuticals saga nutraceuticals research institute conducted rd march various fields related exercise nutrition womens pipeline features indication countryregion development status health health issues one largest tas antimetabolite gastric cancer japan phase iii controlledenvironment rooms japan completed ovarian cancer useurope phase ii institute enabling recreation hypoxic environments guadecitabine dna methyltransferase inhibitor acute myeloid leukemia japanuseurope phase iii myelodysplastic syndromes japanuseurope phase iii equivalent found altitude us filed meters previously difficult recreate well myelodysplastic syndromes astx dna methyltransferase inhibitor japan phase hightemperaturehighhumidity lowtemperaturelow acute myeloid leukemia europe phase iii astx iap inhibitor solid tumors lymphomas us phase ii humidity conditions facility helps advance research astx erk inhibitor solid tumors us phase iii sports nutrition verifying effects fluid astx mdm inhibitor solid tumors us phase iii nutritional intake environments diffuse large bcell lymphoma japan phase opb hematological cancer us phase otsu nutraceuticals tas dutpase inhibitor nonsmall cell lung cancer japanuseurope phase ii tas multikinase inhibitor prostate cancer japan phase ii research institute gastrointestinal stromal tumor japan phase iii tas hsp inhibitor solid tumors useurope phase otsu nutraceuticals research institute established tas solid tumors japan phase tas solid tumors useurope phase advance research intestinal immunity futibatinib fgfr inhibitor intrahepatic cholangiocarcinoma japanuseurope phase ii particular focus intestines play key role tas peptide vaccine urothelial cancer japan phase ii overall health one example institutes research tas prostate cancer useurope phase related enhancing bodys biological barrier tas solid tumors useurope phase iii increasing secretion immunoglobulin iga trabectedin ovarian cancer japan phase canerpaturev oncolytic virus pancreatic cancer japan phase antibody plays crucial role mucosal immunity tbi nyeso sitcr gene therapies synovial sarcoma japan phase iii exploratory rd demonstrated lactic acid bacteria tbi cd car gene therapies acute lymphoblastic leukemia japan phase iii b heightens function mucosal immunity fosnetupitant nk receptor antagonist chemotherapyinduced nausea vomiting japan phase iii lowers probability catching common cold development project unmet needs area defined otsuka based data patientsmap project advanced fiscal otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report beyond otsuka groups csr envisaging variety changes including increase aging populations rapid climate change advances precision medicine associated spread preventive medicine genetic corporate social responsibility testing otsuka group aims indispensable provider products services meet healthcare needs times toward realizing sustainable society therapeutic approaches achieve greater precision applying detailed genetic information patient otsuka group recognizes csr integrated businesses pharmaceutical business proactively promotes csr based corporate philosophy driven corporate philosophy otsukapeople creating fragmentbased drug discovery technology astex new products better health worldwide otsuka pharmaceuticals unique antibody manufacturing group aims achieve highly innovative drug discovery platform technology visterra cysteinomix corporate philosophy find solutions unmet medical needs goal drug discovery platform taiho pharmaceutical well mind engage drug discovery research building network providing research support multiple approaches strengthen proprietary academia bioventures possess advanced research drug discovery platform capable generating new technologies drug discovery seeds strengths innovation include utilizing initiatives innovation research development areas generate innovation collaboration integration proprietary rd platforms technologies core areas otsukas goal generate results innovation seeds various collaborations become indispensable contributor promote groupwide research collaborations peoples health worldwide collaborations external institutions otsukas csr mission csr integrated businesses across otsuka group companies aims grow contributing creation healthy sustainable society pursue objectives supported comprehensive governance system contribution sustainable society cancer immunity gene therapy dementia cancerrelated novel technologies exploration alzheimers disease new drug targets consortium members alzheimers research uk abbvie astex crl eli lilly eisai evotec msd jpnv takeda nutraceutical business otsukas business activities solving social issues csr awareness health issues rising including issues related challenge creating new value expanding new aging populations medical costs spread categories regions combining cuttingedge scientific healthier society society healthier planet environment infectious diseases goal nutraceutical business technological developments unique business health people quality climate change resource recycling conservation water conservation support maintenance improvement peoples model going forward respond various health governance health worldwide thereby contribute longer healthy related social issues continuing implement health corporate governance compliance risk management life expectancy end utilize expertise awareness activities bring issues forefront cultivated pharmaceutical business offering solutions brand furthermore proposing solutions based new concepts address promote activities strengthening collaborations yettoemerge needs social issues eye external institutions changes global landscape take otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsuka groups approach csr toward realizing sustainable society support united nations global compact otsuka holdings became signatory united nations global compact ungc supporting ungcs principles also consider uns sustainable development goals sdgs contributing realization sustainable society business activities otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report rsc evitcaorp rsc evisnefed materiality process determining material issues otsuka group determined material issues based importance society groups businesses material issues determined society health people quality environment climate change resource recycling conservation water conservation governance examples activities materiality social issues goals activities related sdgs csr connected promotion rd unmet needs health support awareness activities peoples health business activities rd antituberculosis drugs improvement maintenanceimprovement mainly exercise drug access health nutrition etc health businesses promotion problem solving strengthening unmet medical contribute unmet needs promotion rd partnerships health health needs solutions unmet needs spread infectious eradication tuberculosis rd antituberculosis sustainable procurement product design deepening communication stakeholders diseases creation system drugs improvement quality quality nutritional needs realization healthful life drug access thorough quality control stable supply promotion customercentric management health increasing aging issues healthy life extension support awareness quality quality activities peoples health responsible promotional activities maintenanceimprovement information provision quality mainly exercise nutrition etc activities explain importance hydration dietary education app sketchcook health p br yo sm tro et nio gn th ef n p inr go b pl ae rm tn eo rslv hin ipg health satu hati one heart programs health people csr social otsuka health comic library health environment contribution together presenteeism creation corporate culture human resource development businesses society unprepared stimulates creativity diversity promotion healthier diversification enhance employee engagement health management society people human resource development people reduce co emissions throughout value chain basic csr diversity promotion people environment health management people reduce environmental impact improving resource efficiency environment consumption gaining stakeholder trust sustainable procurement promotion business activities aimed production pursuing sustainability product design sustainable state society earth impairs sustainability levels value chain thorough quality control environment establishing quality assurance stable supply tst hr oe rn og ut gh n ci mg pc lo iarp cera ge vg ero nv ane cr enance governance u mn ad ne ar gst ea mn ed nin g nw da ee ffr e r ce ts io veu r uc se e r ois fk w e anv ti ero rn rm ee sn ot urces q alu l wlit ey system safety security r ace ts ip vio tin es si b al ne p ir fm oro mti ao tn ioa nl risk identification evaluation management environment provision governance deepening communication stakeholders promotion customer centric management give back local community indonesia pocari sweat manufacturer distributor pt amerta indah otsuka implemented social action program based three core pillars satu hati cerdaskan bangsa one heart education satu hati peduli lingkungan one heart environment satu hati sehatkan bangsa one heart health climate global warming fy goal reduction reduce co emissions change co emissions compared throughout value chain based belief csr integrated also recognize csr social contribution fy businesses across otsuka group aim contribute includes donation activities basic csr realization sustainable society solving social includes governance risk management foundation environmental load fy goal reduction reduce environmental issues businesses therefore focusing business indispensable parts corporate social resource increase simple incineration landfill impact improving compared fy resource efficiency csr connected business activities pursuing responsibility define csr broadly responsible efforts e hn ev air lto hn iem r ent r anec dy cling fy goal higher promotion business activities content recycled plant aimed sustainable state sustainable growth realization healthy companies make coexist society planet conservation based materials pet society earth sustainable society words creation social environment actively advancing csr initiatives bottles value including financial value esg aspects reducing freshwater fy goal improvement understanding water resources water availability water use efficiency risk conservation compared fy management effective use water resources fragile governance longterm improvement strengthening corporate system corporate value governance governance social change risk thorough compliance risk identification evaluation managementsociety partnerships one example otsuka pharmaceutical factorys eradicating tuberculosis approach iv solutions defined basic drugs global health innovative technology fund ghit fund drug high clinical necessity whose manufacturing public interest incorporated association international sales continue required without interruption publicprivate partnership involving japanese group companies manufacture iv solutions locally government private corporations bill melinda gates contributes local communities health foundation welcome trust united nations supply products fair prices creation development program undp funds drug vaccine employment opportunities diagnostic rd order leverage japans high vision pharmaceutical industry ministry health labour welfare level technology innovation fight corporate philosophy otsukapeople creating new products better health worldwide otsuka group actively worlds three major infectious diseases neglected tropical expanding access medicine implements csr initiatives based recognition csr integral part business desire healthy diseases mainly affect developing countries since patients expect satisfactory outcomes universal every day otsuka group carries activities prevent treat diseases contribute maintenance june otsuka pharmaceutical contributed existing treatments also eligible improvement peoples health worldwide world continues face host healthcare issues spread infectious ghit fund associate partner participate clinical trials critical lifethreatening diseases inadequate medical care facilities lack effective therapies also line goal eradicating tuberculosis diseases patients unable access investigational aiming solve issues constantly ask something otsuka work find solutions participated planning project drugs might potential treatment option unmet medical needs majority companies yet address accelerate new treatments tuberculosis pantb expanded access program otsuka group provides moreover issues medical cost inflation mean maintaining improving health issue society whole collaboration since february worldfirst global patients ineligible participate clinical trials individuals must face head addition initiatives raise awareness health among individuals otsuka group crossindustry collaboration charitable non access investigational drugs based application undertakes initiatives maintaining improving health society large including collaboration local communities profit organizations drug industry aims satisfy physician meet prespecified conditions target regimen profiles trp proposed world health organization tuberculosis speeding nutraceutical business pharmaceutical business development new pantb regimen suitable business strategy chemotherapy molecular targeting drugs used treat challenge addressing section specific organs taking challenges new tuberculosis patients initiatives yettobeimagined needs unmet medical needs fields gene therapy cell therapy order keep pace healthy desire people worldwide advances initiatives kidney disease medical technology improvements public health psychiatry neurology shift toward genomic medicine personalized autosomal dominant polycystic kidney disease adpkd extended life expectancy globally also given japans ministry health labour welfare defined medicine tailored characteristics cancer hereditary intractable orphan disease involves rise new health issues otsuka groups nutraceutical psychiatric disorders one five major disease areas individual patient going forward continue progressive development enlargement business centered functional beverages functional rising number patients disorders poses advance rd deliver innovative therapeutic drugs large number fluidfilled cysts kidneys due foods support maintenance improvement pressing global issue however list psychiatric patients greater speed gene mutations kidneys grow many times daytoday health activities enable people worldwide neurological diseases long including schizophrenia original size resulting gradual deterioration live healthy independent lifestyles contribution depression bipolar disorder alzheimersrelated infectious diseases kidney function otsuka pharmaceutical signed health helping treat diseases also dementia rd area challenging underlying tuberculosis one worlds three major infectious comprehensive partnership agreement adpkd helping healthy people stay healthy nutrition causes diseases yet precisely elucidated diseases others aids malaria single japan kidney association working raise awareness current social issues include extending healthy life satisfaction current treatment methods low infectious disease accounts largest number adpkd improve level medical care expectancy responding decreasing birthrates aging however patients families immediate deaths multidrugresistant tuberculosis difficult treat otsuka pharmaceutical signed collaborative populations controlling medical costs set need new therapies psychiatry neurology key resistant number existing therapeutic agreementalso japan kidney associationaimed essence life theme contributing health focus area otsuka group making drugs poses serious public health hazard otsukas practical application basic research young theme engaged product development headway namely development antipsychotic long period research development tuberculosis researchers kidney field openly soliciting information provision activities backed drugs abilify maintena rexulti well selincro treatment culminated approval tuberculosis drug discovery research themes academia scientific evidence based applied expertise drug helps reduction alcohol consumption drug deltyba expanding access bringing kidney research initiativejapan krija platform pharmaceutical business patients alcohol dependency also taking deltyba patients obtaining regulatory approval collaboration academia industry government challenge developing therapeutic drugs diseases countryregion programs developed established japan kidney association signing effective medicines governments international organizations global health maintenance improvement initiatives joint research agreements research institutions drug facility launched stop tb partnership coordination prefectures japan otsuka pharmaceutical enable us carry oncology working alliance partners december otsuka group promoting communitybased health research selected themes medical science advances year year progress deltyba available countriesregions maintenance improvement initiatives well disaster made diagnosis treatment cancer furthermore responding unmet medical needs prevention relief activities example otsuka nevertheless still many diseases expanding indications pediatric care cooperating supplying pharmaceuticals patients pharmaceutical concluded healthrelated partnership effective treatments yet found cancer remaining us nihled prevention trial multidrugresistant fair pricing improved healthcare infrastructure agreements prefectures japan one leading causes death oncology tuberculosis moreover order eradicate tuberculosis aim contributing improved access cooperating local governments find solutions area still many unmet needs another need new therapeutic drug effective pharmaceuticals otsuka group researches develops health issues people living region includes otsuka groups key focus areas stems forms tuberculosis including multidrugresistant extends therapeutic drugs iv solutions applying knowledge expertise topics track record since pioneer developing tuberculosis given need advancing rd address unmet medical needs also work provide dietary education prevention lifestylerelated diseases oral anticancer agents time widely opc new therapeutic drug follow deltyba pharmaceuticals fair prices support improved prevention heat disorders sports promotion womens used anywhere world addition conventional healthcare infrastructure health disaster countermeasures otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsuka groups csr society raising awareness proper hydration activities aimed generations children since launch pocari sweat otsuka pharmaceutical app sketchcook helps teach proper dietary habits people promoting importance hydration various knowledge nutrition world information contexts spurred establishment japan difficult acquire amateur sports association japan sport association busy modern adults jspo study group prevention heat disorders provide japan otsuka group believes active participation diverse range employees free openminded workplace sports activities cooperation efforts prevent heat nature made supplement environment generates innovation sustainable corporate growth end aim foster corporate culture disorders awareness activities began since check app allows encourages creativity invest development human resources actively promote diversity among personnel provided information themes users easily analyze safe workplace environment strive fair hiring evaluation promotion processes respect human rights childrens sports activities occupational safety hygiene nutritional content hydration elderly otsuka pharmaceuticals meal taking dietary education app website includes information section titled protect smartphone picture sketchcook heat disorders section presenting groupwide activities development participants executive human employees interviewed content based jspos guidebook prevention human resources resource development programs human resources department heat disorder sports activities first edition another years otsuka health comic library otsuka global academy otsuka pharmaceutical initiative heat disorders prevention website began publishing created collaboration weather forecasters otsuka health activities raising comic library awareness topic addition otsuka pharmaceutical promote factory sells os oral rehydration solution sound growth basic policy oneyear program selected participants learn provides operational support oshiete kakure dassui development health throughout history innovation always generated corporate dna acquire leadership tasksetting iinkai organization raises awareness ways habits among children next generation produced people otsuka group strive attract problemsolving skills recognizing good input prevent treat dehydration becomes critical editorial supervision japan medical association talented personnel develop individual abilities produces good output otsuka warehouse conducts various feature japan society school health endorsed ongoing basis enable fulfill potential programs intended inspire participants generate japan pediatric society library seeks convey basic health enables us continuously generate innovation unique new ideas programs offer ambitious employees raising awareness womens health knowledge children covering topics makeup variety opportunities including opportunity attend approach japanese average life expectancy years human body nutrition broad easytounderstand business school courses go overseas tours men women healthy life expectancy defined manner medium comics every year choose addition mediumtolongterm business investments cuttingedge technology facilities order improve period person live without bedridden different theme publish new volume comics development nextgeneration executive human literacy without limitation daily activities due health issues donated elementary schools special needs schools resources essential constantly achieve creative otsuka group building educational framework difference average life expectancy healthy japanese schools overseas public libraries innovative sustained growth medium long enables member diverse workforce life expectancy years men women years theme decided based requests term well significant growth corporate value continue developing displaying individual japan therefore extending healthy life expectancy schools opinions organizations involved school launched otsuka global academy potential reflects characteristics group central issue health japan second term plan health cooperation experts various fields oga human resource development program companys business established ministry health labour welfare finding ways deliver factual accurate health aim early identifying nurturing talented personnel also established open recruitment system greater participation workforce women faced information children fun way also working underpin development next generation selfassessment system purpose enhancing issues balancing work childcare nursing care make comics useful part school health executive human resource development programs capabilities employees company personal health effects rapid hormonal changes education since together japan society produced run inhouse across otsuka group otsuka pharmaceutical human resources felt women particular school health cosponsored lectures health experts also aiming realize effective hr development department holds individual interviews every impact everyday work private lives furthermore care usage demonstrations library schools collaboration external agencies programs employee follows issues raise taken period may impact future healthy life continuing evolve years first volume emphasize handing corporate culture interviews conducted employees expectancy response otsuka pharmaceutical developed deepening ability communicate value health seek identify kind candidates required lead every year product containing equol soyderived ingredient help approx books year otsuka group future december system otsuka group internally discloses requirements certain maintain improve health women time total employees across group position job fills among apply employees satisfy requirements apply directly company offering position experience range mental physical changes based disaster relief support participated programs april launched transferred expectations parties agreement open recruitment expertise obtained rd process conduct light obligation company handles items global elearning platform cooperation harvard system utilized employees working group companies japan aimed boosting employee capabilities motivation well invigorating activities spread accurate understanding mental needed emergencies iv solutions therapeutic business school publishing approximately otsuka exchange within group physical changes experienced women related health drugs foods beverages actively engage disaster group employees japan overseas use global system employees submit opinions suggestions regarding current work duties workplace well career plan aspirations human issues well solutions issues evidence relief activities disaster victim assistance platform improve business literacy skills resources department selfassessment system implemented yearly efficacy equol wide range information support measures counteract covid addition individual group companies vigorously cycle goals developing employee potential ensuring assignment nutrition relation womens health topics one example japan supplied products promoting human resource development instance appropriate jobs improving workplace environment found otsuka pharmaceutical website beverages well masks protective clothing otsuka pharmaceutical operated wing voluntary progress nurture brands medical use overseas donated group products leadership study group since participants identify conveying importance nutrition beverages medical products local healthcare internal external issues work teams discuss continue conduct dietary education activities facilities chapters red cross society addition potential solutions formulating proposal explain importance nutrition based expertise making monetary donations organizations consideration taiho pharmaceutical established global gained product development nutritional products one academy corporate university otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsuka groups csr society diversity inclusion health safety female manager ratio employees taking parental leave participants health seminars held participants anzen dojo male employees group employees family members programs otsuka chemical cumulative fiscal basic policy productivity worklife balance also regularly hold basic policy relevant education training activities reported otsuka group actively promotes diversity based groupwide training womens empowerment order otsuka group recognizes mental physical health safety committee meetings form basis belief active participation wide range support diverse employees pursuing career continuity wellbeing every employee indispensable improvements workplace environment furthermore employees advances innovation globalization enhanced childcare nursing care realizing groups shared corporate philosophy major group companies hold joint meeting every year share accordingly corporate group constantly pursuit systems group company opened daycare end committed creating safe workplace reports workplace accidents recurrence prevention innovation endeavoring establish richly diverse centers three business premises tokushima environment continuously implementing initiatives measures workplace environment osaka tsukuba help employees balance childcare help employees maintain improve health otsuka chemical handles chemical substances work conducts various workplace safety initiatives major initiatives approach approach moreover actively conducting diversity promotion include system swift information sharing issues since time concept diversity initiatives groupwide seminars theme major otsuka group companies issued declaration related factory operations among domestic overseas yet gain wide acceptance top management lgbt aim achieving inclusive workplace health strive create workplace locations well regular reporting group safety board actively promoted diversity belief active company developing supplying anticancer environment conducive employee health maintenance directors meetings another key initiative anzen dojo contributions personnel diverse nationalities agents taiho pharmaceutical team realize improvement part efforts led otsuka holdings experiencebased safety training center opened races ages genders disabilities sexual orientations workplace support employees cancer team officers charge health management group part measures prevent occupational accidents characteristics essential creating innovative mainly composed human resources department company cooperate otsuka pharmaceutical health center runs training programs aimed improving safety products ideas drive corporate growth occupational nursing staff aims create workplace insurance association medical professionals activities awareness group employees employees overseas otsuka group stated commitment promoting employees cancer diseases receive aimed improving health employees one activity affiliates third parties classroom instruction diversity otsuka group global code business ethics treatment continuing work taiho pharmaceutical hosting health seminars group employees simulations past accidents center reinforces lessons furthermore group became signatory recognized excellence award families held major cities across japan seminars failures safety knowledge sharpens awareness womens empowerment principles weps set corporate tokyo metropolitan government outstanding aimed communicating groups initiatives health danger develops ability identify potential risks principles jointly developed united nations global initiatives support framework helps cancer introducing otsuka pharmaceutical health insurance recognition activities improve health safety compact ungc un women offers guidance patients balance treatment work association disseminating information relevant education establish safety culture anzen dojo empower women workplace furthermore otsuka pharmaceutical established heartful improving health employees families another otsuka chemical received rc outstanding award demonstrate commitment signatory kawauchi tokushima city special purpose activity groupwide tokushima health project known japan chemical industry association th annual weps introduced number systems meet subsidiary subsidiary enables people disabilities tokj launched theme creating lively responsible care awards weps group companies japan notable examples fully realize potential cheerful workplaces lowering risk lifestyle diseases work interval system mandates minimum scope figures nine companies otsuka pharmaceutical otsuka project targets tokushima regionwhere greatest rest periods workers family smile support pharmaceutical factory taiho pharmaceutical otsuka warehouse otsuka chemical concentration group employees live workand focuses otsuka foods otsuka pharmaceutical dc otsuka america pharmaceutical system encourages employees work home raising awareness health issues region whole pharmavite necessary deal childbirth childcare childrearing united nations entity gender equality empowerment women project promotes walking exercise healthy diet revised telework system increased flexibility nursing care thus achieving better work efficiency improving workplace health safety purpose creating safe secure workplace factories business sites group company external recognition japan established safety health committees defined industrial safety health act actively carry workplace health safety inspections well necessary activities ensure appropriate management health operations workplace environment addition anzen dojo external recognition nadeshiko brand platinum kurumin eruboshi diversity management system selecting companies kurumin certification system based selection actively promote employment certification system based act promotion womens system recognizing companies advancement women act advancement measures participation advancement improved corporate value ministry economy trade support raising nextgeneration workplace companies diversity management industry tokyo stock exchange children platinum kurumin recognized excellent efforts ministry economy trade selected otsuka holdings certification kurumincertified empower women workplace industry companies carried ministry health labour award otsuka pharmaceutical scope survey otsuka holdings higherlevel initiatives welfare otsuka pharmaceutical ministry health labour eruboshi highest grade health productivity management health productivity health productivity management welfare otsuka chemical outstanding organization white management outstanding outstanding organization platinum kurumin large enterprise category organization sme category otsuka pharmaceutical factory otsuka holdings otsuka pharmaceutical large enterprise category otsuka electronics jimro taiho pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka techno otsuka wellness vending kurumin otsuka pharmaceutical others health productivity management outstanding organization recognition program examines organizations working overcome healthrelated challenges local communities promote healthconscious activities led nippon kenko kaigi recognizes organizations outstanding efforts health productivity management otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsuka groups csr society joint business partner audit pharmaceutical companies details otsuka group quality sourcingprocurement vision policy otsuka group four pharmaceutical companies conduct please visit website joint business partner audits shared suppliers raw httpswwwotsukacomencsrsociety materials began audits applying proprietary qualityprocurementhtml help build sustainable society otsuka group seeks achieve sustainability addressing environmental social issues methodologies including auditor skills training program establishing quality assurance structure ensures safety reliability every stage value chain production quality rd procurement control patient logistics sales marketing customer safety production quality control patientcustomer safety rd basic policy quality control patientconsumer safety otsuka group always puts customers first seeking otsuka group always puts customers first ethical considerations concerning replacement animal use reductionminimization make products gain trust promote collaboration end built maintains safety control operation appropriate rd number animals used refinementminimization joint activities among group companies taking account systems take account characteristics use experimental animals verify efficacy safety animal suffering based conduct researcher characteristics businesses include businesses include pharmaceuticals foods rd times necessary otsuka group complies education internal inspections evaluations pharmaceuticals foods beverages chemicals cosmetics beverages chemicals cosmetics proper assurance related laws ordinances guidelines striving uphold implementation experiments involving animals quality foundation efficacy safety enable approach scientifically valid methodologies ethical considerations pharmaceutical products used medical care viewpoints animal protection welfare including ethics development otsuka group strongly committed quality addition complying laws regulations lives animals preservation environment development pharmaceuticals confirm safety commitment began words busaburo otsuka country example pharmaceutical medical safety experimenters effectiveness candidate compounds conducting founder otsuka group quality vital factory devices act japan engage quality control post inhouse management system developed clinical trials cooperation healthy individuals packaging manufacture market putting marketing surveillance ensure safety accordance implemented rules experiments involve animals patients recognizing importance ethical considerations consumers position commitment gqp gvp standards also make reports well established animal experiment committee regarding human rights personal information otsuka passed employees ever since believe compile revise various documentation submission properly carry animal experiments breeding group implements clinical trials compliance ethical ensuring stable supply highquality products contributes relevant regulatory authorities also established animal experiment committee evaluates whether principles standards including ichgcp international sustainable society believe focus system constant global pharmacovigilance collects proposed animal experiment plan appropriate based standard implementation clinical trials active efforts ensuring quality human resource assesses product safety information including side effects rs principles replacementavoidance pharmaceutical products development building appropriate systems continue promptly provide results monitoring otsuka groups production quality safety control medical institutions relevant parties systems comply legal regulatory requirements gqp good quality practice governmental industry standards including gvp good vigilance practice partners surveyed pharmaceutical medical devices act food selfassessment questionnaire global product quality team activities procurement sanitation act group companies also work acquire pharmaceutical business cumulative international certifications iso quality since otsuka pharmaceutical group companies basic policy guidelines provide specific descriptions iso fssc food safety conducted activities enhance compliance gxps otsuka group together business partners aims provisions vision policy order ensure range processes development production contribute building sustainable society promoting stable supply products perform advance risk finished product among initiatives improve quality csr procurement takes consideration factors assessments key raw materials identify potential risks production departments otsuka group employ control systems hold meetings attended management legal regulatory compliance environment take countermeasures also make sure traceability system covering stages value chain personnel well groupwide meetings protection human rights source raw materials multiple companies principle raw material procurement production distribution pharmaceutical business established global product products use palm oil example otsuka pharmaceutical sales thereby enabling thorough management throughout quality policies activities carried globally approach confirms business partners rspo members entire value chain include ensuring reliability quality data compiling across entire value chain otsuka group engages purchasing raw materials moreover years production departments procedural manuals business activities safe reliable socially acceptable roundtable sustainable palm oil held global production meeting aimed group gxp umbrella term gcp gvp gmp gdp etc compliance laws regulations commencing wide improvements sharing techniques information transactions supplier perform screening checks collaboration business partners meeting attended approximately quality control activities ensure quality raw materials guarantee stable conduct surveys business partners using csr employees involved production group companies nutraceutical business procurement also conclude basic transaction agreement procurement selfassessment questionnaire published un countriesregions addition failure case study meetings otsuka pharmaceutical established quality division case new supplier transactions determined global compact network japan asked companies environmental management information exchange meetings purpose facilitating quality improvement carried due diligence complete survey received responses began respectively meetings safety control products nutraceutical business aim mutually sustainable development fair nine companies selected responded participants share presentations opinions case studies furthermore establishment quality assurance equitable transparent procurement establishment assess business partners respect collaborative measures technological development office implemented system based gmp healthy relationships business partners achieve legal regulatory compliance also respect address quality safety cost environmental issues pharmaceuticals system enables centralized management formulated share business partners activities regarding human rights labor environment future outlook overseas development processes identifying verifying risks arising otsuka group sourcingprocurement vision policy anticorruption measures results survey provided global production meeting also present awards changes investigating causes taking remedial takes account factors human rights labor issues partners feedback promote csr procurement employees made significant contributions action risks manifest may factories environment anticorruption measures going forward hold briefing sessions partners production activities lay foundations japan manufacture nutraceuticals certified also formulated sourcingprocurement questionnaires sent business partners meet predefined criteria improvements productivity conduct personnel training fssc food safety standard otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsuka groups csr society collaboration pharmaceutical meeting opportunity participants review consumers develop personnel help resolve social reducing food loss nutraceutical departments preceding years quality control performance work issues hold monthly training programs three formats otsuka group seeks address food loss issues product quality departments pharmaceutical business improving quality control developing personnel sharing group seminars elearning satellite broadcasting producing foods beverages longer shelf lives nutraceutical business jointly hold annual global product reports illustrate need predictive risk management similar fashion pharmaceutical business expiration dates indicated month rather quality meeting meeting attended around production activities based importance learning established dedicated unit comprising multiple departments day products unsuitable consumer market managers quality supervisors pharmaceuticals examples issues well successes review marketing plans sales promotion materials due shortdated poor condition external packaging nutraceuticals companies nine countries nutraceutical consumer products ensures reasons reduce food loss marketing sales promotion activities appropriate began selling products group employees comply laws regulations initiatives helped us eliminate approximately tons food loss logistics basic policy specifically improving logistics quality introducing otsuka group handles products relate directly systems truck dispatch vehicle monitoring promotion customercentric management human life including pharmaceuticals foods beverages enable better tracking transport delivery status ensure rigorous control maintenance initiatives product quality throughout distribution actively take include computerizing basic policy treatment need nursing care others said measures ensure stable supply event natural warehouse operations october otsuka group announced declaration difficulty opening cap muscular disaster emergency situation group also promotes reduce incorrect customercentric commitment way putting strength issues based feedback redesigned environmentally friendly logistics operations measures shipments mispicks corporate philosophy practice promotion customer container easier open also created websites reducing co emissions thereby helping quality centric management targeted activities material provide product information japanese english chinese improvement issues conducting business recognize respecting spanish added qr codes product labelling link approach warehouse navigation system higher efficiency consumer rights important human rights issue websites otsuka group delivers products throughout japan mainly diverse assortment shipping forms standardized declaration customercentric commitment establishes basic os approved food persons medical conditions intended via group company otsuka warehouse ensure control digitalized benefits include lower mishandling rates policies stating commitment social responsibilities provide water electrolytes order maintain proper water electrolyte maintenance product quality otsuka warehouse set orders changed balance persons mildtomoderate dehydration approved consumer corporation fulfill pursuing customercentric affairs agency gdp promotion office facilitate appropriate logistics otsuka warehouse working ensure stable supply management making appropriate decisions based accordance gdp guidelines pharmaceuticals establishing distributed storage facilities across japan dialogue stakeholders disseminate principles gdp guidelines among maintain adequate product stocks reflect product personnel engaged manufacture distribution characteristics furthermore pharmaceuticals framework inculcating customercentric example improved product os jelly pharmaceuticals training drills quality business continuity planning bcp established mindset employees enlarged cap diameter millimeters management systems document control administration ensures essential products delivered customerfacing employees group companies japan previous design new design outsourced processes facility equipment maintenance needed addition securing stock measures include meet twice yearly share best practices customer service larger cap storage transport operations assessment supplier developing emergency response system transporting makes product improvements helps foster customercentric product easier customer eligibility among others addition conduct products example registering vehicles authorized open corporate culture regular training ensure compliance internal standards access restricted areas exchanging mous shippers procedures warehouse owners partners cooperation enhancing information exchange also strive standardize data management system transport emergency relief supplies customers mechanisms specifications order facilitate collaboration reflecting customer feedback cooperation shippers logistics operators group company establishes dedicated customer contact gdp good distribution practice points patients healthcare professionals general consumers provides appropriate training employees packaging produced group companies japan work example assignment specially exception certain products trained female operators enables us better answer inquiries space limitations ensure understandability labelling sales marketing products designed women approach helps us addition information required law following deepen communication customers provide appropriate information presented instructions storage opening basic policy given society demands transparency relationships information reflect customer requests suggestions precautions use easytoread list allergens contained otsuka group believes responsibility deliver pharmaceutical companies healthcare product improvements mandatory recommended items clear indication highervalue products services customers organizations striving ensure code adherence one product improvement os os packaging materials based customer feedback continue engage suitable promotion advertising activities order fulfill duty pharmaceutical company jelly produced otsuka pharmaceutical factory make improvements example otsuka foods comply laws regulations communicate ensure practice ethical patientoriented medical care products foods persons medical conditions redesigned allergen labelling adding list allergens customers appropriate manner received feedback elderly individuals customers receiving package separate location comprehensive approach nutraceutical list instructions precautions bon curry children approach consumer products businesses illustrations previous design new design otsuka group expanded jpma promotion nutraceutical business contributes solutions social added make code prescription drugsa code behavior issues providing creative products directed maintaining details declaration information easier healthcare professionals issued japan pharmaceutical improving peoples health offering useful health customercentric commitment understand please visit website manufacturers association jpmato formulate information otsuka pharmaceutical established scientific consumers purchase httpswwwotsukacomencompany code practice covering group company effort affairs department gather disseminate information peace mind customer engage appropriate collaboration based relationships products related knowledge latest academic trust stakeholders including medical practitioners information order provide appropriate information otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report environment climate change fy goal reduction co emissions compared fy otsuka group global environmental council climate change due global warming causing serious environmental issues worldwide scale otsuka groups environmental policy severely impacting biological water resources recognize major risk global operations otsuka global group contributes health people otsuka group companies strives advance group committed creating decarbonized society thereby sustainable society aiming reduce worldwide otsuka group works sincerely reduce essential company contributes greenhouse gas ghg emissions across entire value chain order help achieve paris agreement goal impact businesses global environment health people worldwide help realize holding global average temperature increase c preindustrial levels seeks contribute creation sustainable society sustainable society always taking account protect nature future earth global environment value chain pursue otsuka group global environmental council initiatives efficient energy use taiho pharmaceutical validated science business activities based trademark qualities comprises groupwide coordinator otsuka holdings co reduction based targets sbt initiative autonomy proactiveness creativity executive officers group company tokushima prefecture number otsuka order achieve new goals optimize guidelines responsible jurisdiction matters related group production sites concentrated installed energy use introduce renewable energy continue environment secretariat matters deliberated climate change cogeneration systems otsuka chemical otsuka promote reduction ghg emissions throughout council approved board directors play part controlling global warming reducing pharmaceutical factory systems generate electric value chain otsuka holdings shared environmental co emissions power natural gas converting waste heat management policies otsuka group council steam hot water supplied nearby goals resource recycling conservation promotes initiatives contribute solutions global continue improve resource efficiency help group companies furthermore cogeneration system reduction greenhouse gas social issues related earths environment introduced february otsuka pharmaceutical emissions scope create zerowaste society factorys toyama factory supports business continuity compared water conservation promote sustainable use water conservation otsuka group global environmental council organization plan reduces annual co emissions approximately reduction greenhouse gas tons contributes energy efficiency stable emissions scope compared recycling clean return groupwide coordinator drug supply international initiative led united nations global compact ungc world environmental compliance otsuka holdings director resources institute wri world wide fund nature wwf validates continue improve environmental management working reduce co emissions switching companies co emission reduction targets align scientificallybased renewable energy july started introducing reduction scenarios order achieve paris agreement goal holding global system increase effectiveness compliance average temperature increase c preindustrial levels cofree electricity derived renewable energy scope direct emissions reduce risks secretariat sources emit co otsuka group factories scope indirect emissions energy sources scope indirect emissions otsuka holdings research centers tokushima prefecture otsuka otsuka pharmaceutical otsuka group determined materialities pharmaceuticals fukuroi factory november thirdparty verification ghg emissions environmental initiatives climate change resource expanded introduction otsuka foods shiga factory order improve transparency reliability recycling conservation water conservation overseas nutrition sants spain factory environmental data otsuka group ghg council members set goals carrying activities aimed otsuka total co emissions emissions scopes co emissions energy achieving part initiatives otsuka otsuka pharma taiho otsuka otsuka otsuka sources including energy consumption scope pharma ceutical pharma chemical warehouse foods thousand tonsco tons million groups five major companies japan working ceutical factory ceutical category verified thirdparty organizations helps acquire integrated iso certification international japan us identify emissions trends implement improvements standard environmental management systems part indonesia continue expand scope verification efforts promote activities efficient india enhance reliability data highly effective south korea ghg emissions throughout value chain going forward group work together toward north america scope realization decarbonized society ultimately china sustainable society raising awareness understanding europe scope environmental issues conducting environmental others training employees generating synergy categories collaborations group companies thousand tonsco scope otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka total co emissions left co emissions per sales right chemical otsuka foods scope production sites consolidated otsuka group december otsuka group companies japan overseas iso certified accelerate efforts achieve group goals working category acquire integrated iso certification group validation otsuka pharmaceutical taiho pharmaceutical goals sbt initiative purchased goods services scope otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical ghg reduction goals set otsuka pharmaceutical otsuka chemical otsuka foods otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsuka groups csr environment resource recycling conservation water conservation fy goals reduction simple incineration landfill compared fy fy goal improvement water use efficiency compared fy higher content recycled plantbased materials since establishment otsuka groups operations deep connection water resource essential pet bottles life products use water raw material actively contributed treatment order realize sustainable society ongoing corporate growth global shift sustainable business prevention diseases also maintenance promotion health therefore recognize water models grow without impacting environment necessary continue providing products contribute important resource consider conservation critical global issue moreover water resources unevenly health people worldwide otsuka group raise resource efficiency throughout value chain build distributed across different countries regions faces different risks otsuka group therefore sustainable system recycling conservation resources including biological resources cooperates stakeholders conducts ongoing water conservation initiatives intake discharge including cultivation water resources conscientious use clean return aim sustainable water use initiatives achieve zero waste otsuka group plastic policy evaluating water risk production sites water usage water use efficiency fiscal otsuka groups total global waste volume considering environmental risk region also thousand million fundamental concept tons effective use amount including important sustainable growth diverse business pet bottles comprise majority plastic containers material recycling composting heat recovery models otsuka group operating around world packaging used consumer products group companies tons total since otsuka group conducted water risk reason believe promoting pet bottle recycling furthermore simple incineration volume assessments production sites using water risk reduce reliance fossil fuel thereby contribute tons mainly japan landfill volume environmental conservation plan use pet bottles assessment tool aqueduct developed world tons mainly overseas going forward promote manufactured recycled plantbased materials increase resources institute wri understand minimize activities reduce waste disposal volumes together percentage sustainable resource use production impact risk waterrelated business activities group companies japan overseas processes globally percent percent going forward conduct specific assessments approach seeking reduce waste generation wasted resources zero moreover advance pet material recycling essential recycle promote activities tailored region target reuse recycled materials raw materials pet bottles use raw material together various effective management use water aim outside japan left japan left water use efficiency right generation use heat energy incineration accordance eu ssccooppee pllr opdruocdtiounc stiitoesn sf itthees c oonfs otlhidea tcedo notssoukliad gartoeudp otsuka group japanese standards includes use fuel solid fuel conversion stakeholders advance global efforts proper collection conservation sustainable use water resources recycling used pet bottles total waste volume vision environmentally friendly products otsuka group entire line consumer products endeavor use tons going beyond making products low impact development consider environmental impact throughout packaging supports sustainable society value chain raw material procurement disposal well needs times resulting changes tons material recycling use plastics made petroleumbased materials society way contribute solutions global environmental issues increasingly diverse social issues composting conversion tons feed reuse etc promote use recycled plantbased biodegradable power generation heat use materials unique formulation allows pocari sweat ice slurry stored room temperature tons fuel conversion tons landfills promote use reusable packaging developed pocari sweat ice slurry focus core body temperature regulation simple incineration support active people hot environments unique formulation drinkable ice product allows tons others goal stored room temperature conveniently frozen use even melts liquid achieve percent higher content recycled plant returned slurry state refreezing also enables energy savings transporting total waste volume based materials pet bottles storing product tons introduce alternative packaging eg paper increase use scope production sites consolidated otsuka group cans drink products bon curry warmed microwave still box step promotion drink bottle recycling introducing launched bon curry worlds first commercial retort pouch food product reusable packaging zerowaste sales circular heated microwave still box saves consumers time trouble boiling water initiatives targeting issue plastic waste distribution model also includes use sports bottles powder products putting curry plate warm product environmentally friendly initiative aimed solving issue plastic waste require open flame water preparation promote use alternative packaging concurrently formulated otsuka group plastic policy pursue using recyclable materials drink containers apply okinawa limited bon curry products contribute sustainable recycling resources worlds first quadchamber infusion bag group provides products contribute peoples otsuka pharmaceutical factory develops products management vision best health otsuka group continue measures assure partner clinical nutrition focusing development kit products easy safety quality containers packaging healthcare workers use also reduce medical errors risk infection otsuka pharmaceutical factory behind development firstever quadchamber bag used elneopa highcalorie infusion vitamin mixture containing glucose electrolytes amino acid multivitamin trace elements groundbreaking design makes possible aseptically prepare mixture single push also saves resources enables efficient transportation reduces disposal waste otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report governance board directors meetings candidates audit supervisory board members board directors convenes regularly month committee obtains approval audit supervisory holds extraordinary meetings necessary make important board prior reporting board directors business decisions supervise execution operations candidates put forward representative directors director selection criteria remuneration corporate governance company aims become indispensable contributor corporate governance committee discusses matters peoples health worldwide targeting sustainable related remuneration system standards otsuka holdings co ltd company committed promoting sustainable increase corporate value medium growth enhanced corporate value medium directors audit supervisory board members long term realizing corporate philosophy otsukapeople creating new products better health worldwide meet long term toward aim company works ensure reports board directors commitment adopts basic policy making transparent fair timely decisions fulfilling corporate social responsibility overall diversity directors appoints people corporate governance structure living expectations stakeholders including customers business partners employees local communities insight expertise experience needed realize addition committee deliberates matters related shareholders ongoing dialogue maintain appropriate effective corporate governance enhancement corporate governance structure internal directors particular comprehensively evaluate reports board directors necessary experience expertise insight attributes board directors meeting attendance outside directors female directors candidates ensure qualities needed audit supervisory board members implement groups corporate philosophy code audit supervisory board members attend express business ethics management strategies opinions meetings board directors monitor performance duties directors terms initiatives strengthen corporate governance corporate governance committee legal compliance soundness management company discloses basic approach corporate governance corporate governance guidelines available corporate establishment otsuka holdings february company established corporate audits striving improve effectiveness audits website term directors set one year governance committee aim increasing audit supervisory board members also share information decision adopt directors retirement benefits system corporate governance guidelines corporate officer system adopted transparency objectivity management advisory exchange opinions appropriate relevant httpswwwotsukacomencompany two outside audit supervisory board members body board directors committee discusses departments including internal audit department governancepdfguidelinepdf three outside audit supervisory board members matters relating corporate governance including internal control department administration department stock options performancelinked remuneration introduced corporate governance report stock publicly listed december nomination directors audit supervisory board finance accounting department well httpswwwotsukacomjpcompanygovernance first mediumterm management plan announced members remuneration system standards accounting auditor pdfreportpdf available japanese two outside directors three outside audit supervisory board directors reports results deliberations members second mediumterm management plan announced board directors committee consists president evaluation effectiveness board directors three outside directors two outside audit supervisory board director charge administration four outside january february every year company members overview corporate governance structure otsuka group global code business ethics established directors president serves chair committee conducts questionnaire survey directors audit board directors also includes outside corporate governance guidelines established supervisory board members results survey directors advances execution management plans internal whistleblowing system otsuka holdings major content deliberations reviewed company attorney reviewed group companies established reporting independent supervises companys management also assumes body outside company nomination evaluated board directors meeting march roles responsibilities enhance profitability three outside directors three outside audit supervisory board corporate governance committee discusses questionnaire items follows members capital investment efficiency order promote effectiveness board directors evaluated validity fairness matters related appointment composition board directors sustainable growth company increase system granting stock options conditional progress dismissal directors audit supervisory board directors understanding knowledge business mediumterm management plan introduced corporate value medium long term members reports board directors regarding fields specific management strategies plans corporate governance guidelines revised company secures soundness establishes corporate governance committee established solid corporate governance structure living social started evaluate effectiveness board directors based questionnaires completed directors audit shareholders meeting expectations ensuring audit supervisory supervisory board members board members independent started hold reporting meetings outside directors electsdismisses electsdismisses electsdismisses outside audit supervisory board members improve board directors audit directors performance understanding groups management business duties collaboration accounting auditor two female directors corporate consults board directors ap cce ora ut nio tin na gl aa uu dd ii tt ss audit supervisory board well internal audit department corporate governance guidelines revised governance recommends directors outside directors boa rd mud ei mt ru sp e r ov fi wor hy rh ei sr td ri cm tee dd su tm oc kt e brm em cn oa mg pem ene sn ip ol na n p la nn io nu trn oc de ud ced committee appointsdismisses outside members corporate organization otsuka group global conflict interest policy established president company audit supervisory board four outside directors three female directors representative director ceo cooperates cooperates defined companies act company governance structure march instructs reports accounting audits accounting auditor established board directors audit supervisory company audit internal audit department board also engages accounting auditor articles form organization supervisory board cooperates incorporation stipulate number directors shall directors outside directors independent directors exceed number audit supervisory term directors year maa tep rp iaro l mva al tf ers gre oe uti pn g b rt dh se consp ur li ar tion board members shall exceed five audit supervisory board members management corporate ex post outside audit supervisory board independent auditors guidance auditors facto reports members accounting auditor deloitte touche tohmatsu llc subsidiaries shareholders meeting board directors audit supervisory board members etc otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report cooperation outside directors companies furthermore given outside directors skill matrix directors audit supervisory board members cooperation audit supervisory board outside audit supervisory board members satisfy order establish effective corporate governance structure supports sustainable growth company appoints operation board directors meetings requirements independent directorsauditors prescribed individuals wideranging business experience advanced expertise broad fields extensive knowledge directors governancerelated matters tokyo stock exchange tse company audit supervisory board members table summarizes areas experience expertise directors function board directors determining registered tse audit supervisory board members direction management strategy ii monitoring business respect internal audit department global technology rd strategic finance legal company healthcare major planning compliance risk administration qualifications business production accounting analysis execution management strategy companys internal audit department reports directly marketing sales management public health etc iii understanding perspectives major investors president department regularly conducts audits stakeholders based internal audit rules verify operations iv risk management executed appropriately efficiently v cooperation information sharing regard assets business company operating company affiliated companies department submits audit support system outside directors reports president directors audit supervisory overall functioning board directors board members need improvement perspective effectiveness department recommends remedial actions later confirms implementation thereby contributing optimization business execution department also shares information cooperates audits audit supervisory board members accounting auditor internal control department companys internal control department handles internal controls regarding financial reporting company affiliated companies department formulates rules manuals pertaining internal controls provides training ensures employees thoroughly understand operational rules department also works cooperation internal audit department continuously monitor status operations rationale selection outside directors outside audit supervisory board members basis internal control system management personnel reliably evaluated attendance rate basic approach internal control system audit rationale selection board supervisory current status described corporate governance directors board meeting report submit tse available meeting japanese outside yukio matsutani mr matsutani provided appropriate suggestions advice companys management directors independent standpoint outside director objective expert viewpoint based abundant experience extensive knowledge healthcare accounting audit welfare fields high level expertise overall healthcare times company signed auditing agreement ko sekiguchi mr sekiguchi provided appropriate suggestions advice companys management independent standpoint outside director objective expert deloitte touche tohmatsu llc accounting auditor viewpoint based abundant experience extensive knowledge corporate manager high level expertise pharmaceutical business times audit accounts fair impartial standpoint certified public accountants audited companys yoshihisa aoki mr aoki provided appropriate suggestions advice companys management independent standpoint outside director objective expert viewpoint independence criteria independent officers accounts yukitaka maruchi koichi niki hirofumi based abundant experience track record extensive knowledge corporate manager abundant experience expertise network food industry times selecting outside directors outside audit otani assisted eight certified public mayo mita ms mita securities analyst abundant experience corporate analysis based supervisory board members company looks accountants six individuals certified high level insight objectively observing analyzing companies expected individuals wealth knowledge extensive public accountants audited companys accounts provide appropriate suggestions advice companys management independent standpoint outside director objective expert viewpoint experience various fields company requires done less seven consecutive years outside audit hiroshi mr sugawara specialized knowledge certified public accountant well abundant candidates ability adequately exercise therefore description omitted supervisory sugawara business experience company determined able use board experience expertise audits company times times management oversight functions fair objective members monitoring supervision auditing management succession plan yoko wachi attorney ms wachi wellversed corporate legal affairs company determined able use experience expertise audits company neutral objective viewpoint independence company continues develop implement executive times times standards outside directors defined human resource development programs identify talented kazuo takahashi mr takahashi held major positions internal control departments many years corporate governance guidelines form basis personnel early systematically nurture nextgeneration abundant experience corporate management company determined judgements independence outside directors management candidates equipped qualities skills able use experience expertise audits company times times addition require previously called corporate philosophy status outside directors outside audit supervisory board members given risk conflict interest general shareholders company believes outside officer qualifies independent directorauditor engaged execution operations group programs regularly reported board directors attendance board directors meetings audit supervisory board meetings mayo mita listed newly appointed outside director th general meeting shareholders held march otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report srotcerid ichiro otsuka tatsuo higuchi yoshiro matsuo yuko makino shuichi takagi sadanobu tobe masayuki kobayashi noriko tojo makoto inoue yukio matsutani md ko sekiguchi yoshihisa aoki mayo mita tidua yrosivrepus draob srebmem summary evaluation fiscal results analysis evaluation overall effectiveness board directors fiscal summarized increase opinions stating improvement previous year regarding items questionnaire opinions noted particular improvement cooperation yozo toba outside directors cooperation audit supervisory hiroshi sugawara cpa board function board directors determining yoko wachi attorney direction management strategy ii monitoring business respect execution management strategy kazuo takahashi regard operation board directors meetings agreement deliberations improved however issues identified criteria whether items deliberated subsidiaries deliberated subject resolution board directors appropriate allocation deliberation time early provision reference materials confirms need review matters relating item basis evaluation believe companys board directors functioning appropriately perspective effectiveness nonetheless strive make improvements issues identified evaluation review addition work strengthen corporate governance discussing best practices role holding company cooperating monitoring subsidiariesremuneration directors audit supervisory board members content remuneration directors companys remuneration plan directors audit addition following extensive study board fixed fixed remuneration directors holding company determined based duties responsibilities including supervisory board members designed achieve directors corporate governance committee remuneration formulation group strategies monitoring group operations strengthening corporate governance sustainable growth enhanced corporate value decision made design implement restricted remuneration directors serve concurrently directors subsidiaries operating companies determined based duties responsibilities including execution business based group strategies formulated otsuka holdings medium long term group also ensuring stockbased compensation system starting fiscal formulation strategies operating company strengthening corporate governance remuneration shall exceed functions business execution management upper limit remuneration resolved shareholders meeting supervision exercised appropriately maintaining composition remuneration performance remuneration determined based rate achievement fiscal years targets consolidated revenue consolidated transparency fairness companys basic approach remuneration directors otsuka holdings linked bonus operating profit consolidated business profit rd expenses progress respect mediumtolongterm remuneration directors audit supervisory board holding company otsuka group consolidated performance targets appropriate business management compliance corporate governance along individuals personal performance members follows remuneration directors excluding outside directors corporate governance committee deliberates upon items reports results deliberations directors company consists fixed remuneration according decisions made board directors remuneration levels title position bonuses linked results operations considering need acquire motivate outstanding shortterm incentive well stockbased compensation sharebased meeting board directors held february company resolved introduce restricted stock remuneration payment plan incentive plan sustainably improve mediumtolongterm performance corporate value company personnel take responsibility companys mediumtolongterm incentive remuneration outside plan designed provide effective remuneration system combining multiple release conditions transfer global business activities company sets remuneration directors audit supervisory board members consists restrictions including set performance evaluation period performance achievement principle granting shares transfer restrictions requiring evaluation performance several fiscal years simultaneously first fiscal year levels fully commensurate roles responsibilities fixed remuneration shares transfer restrictions issued plan intended comprise remuneration system reflects progress expected personnel achieving mediumterm management plan end remuneration plan combines multiple performance achievement requirements based performance indicators third mediumterm management plan announced may b composition remuneration directors remuneration system excluding outside directors regard remuneration directors responsible performancelinked remuneration percentage business execution company formulated total remuneration varies according companys total remuneration officer category type number applicable officers remuneration system closely linked performance singleyear mediumtolongterm consolidated results total remuneration etc type million individual fiscal years well medium operations system emphasizes mediumtolong total remuneration etc eligible officers million fixed stock long term emphasizing sustainable enhancement term enhancement corporate value performance remuneration compensation bonus corporate value addition cash remuneration linked bonuses designed variable directors company also provides sharebased payments closely range fixed remuneration stock excluding outside directors linked shareholder value outside directors audit based compensation range fixed supervisory board members paid fixed remuneration remuneration maximum performancelinked remuneration audit supervisory board members paid remuneration varies according percentage total remuneration excluding outside audit performance total supervisory board members outside directors audit c remuneration directors subsidiaries supervisory board members governance remunerationrelated decisions operating companies otsuka group activities remuneration committee board directors remuneration directors subsidiaries decisions related remuneration directors audit operating companies determined based duties supervisory board members made board responsibilities including execution business directors based report corporate governance operating companies based group strategies formulated regarding directors conflict interest committee advisory body board directors company formulation strategies operating operational judgements decisions made relation interests individuals committee deliberates matters including companies strengthening corporate governance best interests otsuka group otsuka group established otsuka group global conflict interest remuneration system levels remuneration exceed cap director remuneration resolved policy prevent conflicts interest also applies directors compliance deciding remuneration efforts made enhance general meeting shareholders objectivity means utilizing external data noted restricted stockbased determining remuneration directors audit compensation system newly implemented fiscal supervisory board members current term board also apply directors excluding outside directors corporate governance committee directors groups major subsidiaries deliberate number times board directors makes final decisions receiving corporate governance committees report decisions appropriate otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report directors audit supervisory board members march directors outside directors och tsir uo ka ha igts uu co hi mo th si uro mu ak ti u tani k seo kiguchi ao os kh iihisa c r dh e irpa ei r cr e tm oea rnn aa tn ivd e p r dr e ie rp es ri ced ts oe en rn ct en oid v e de irn eio ctr ranaging outside director outside director outside director profile profile profile profile profile profile apr joined otsuka pharmaceutical factory inc mar joined otsuka pharmaceutical co ltd apr joined otsuka pharmaceutical co ltd apr intern pediatric department st lukes international hospital apr joined mitsubishi corporation apr joined itochu corporation jun executive director director consumer products development jun senior managing director otsuka pharmaceutical co ltd jan vice president associate general manager general affairs oct joined ministry health welfare ministry health may joined boston consulting group jun executive officer itochu corporation division otsuka pharmaceutical co ltd pharmavite department otsuka pharmaceutical co ltd labour welfare jan general manager sterrad business division johnson johnson apr managing executive officer president food company itochu jun managing director responsible consumer products publicity nov executive deputy president executive director otsuka jun vice president general manager general affairs aug directorgeneral health policy bureau ministry health labour medical k k johnson johnson k k medical company corporation p cr oo lo tt dio n development division otsuka pharmaceutical jun p eh xea cr um ta ivc ee u dt ii rc ea cl oc ro r e l st pd nsible us business otsuka nov see np ia rt vie cn e p ro est du ek na p gha er nm ea rac le mut aic na al gc eo r fl td h e general affairs aug dn ird e cw toe rlf nar ae tional sanatorium tama zenshoen nov p nre os wid je nt sen nd pr ap rr mes ae cn et ua tt ii cv ae l ki r ke c tor janssen kyowa co ltd apr pree sm idb ee nr ff oth oe b co oa mrd p ne yn io tor cm hua n ca og ri pn og r e ax tie oc nutive officer de e eac c cy e p r e p px h x h ee ea p sc cr rr iu um dest ea ai ie nv vc cne e te e au uad ntt ti eii ir dvc cpe ea c u r l lt eo f fy pia ar r p rc ce er rt tc eo se esor rs iy nde r e aon nr n tc c ct ith vs eu n k dn dad rp r ed h e ce p tov r rm e lo oecp n te sm tu ue tt kiin v ac eat p l ho f aiat r rcs e mu cok aora cy r e ui tc ics u alk j j ju u un n l p p c e p ch xr ro oe eea sc r um dl lte e ta id dvn nc e te u cnt n uii rdc ra c er rl ne oc e tp pro r r oe e stl e est n ud nt k ta aat ipv vhe e drmi ir eac c ct e r c cat els ou ck p tl sh uda kr hac oe ldu nic ga sl j mul r e c hx ee oat np le n ia r ilnr nrg tt gdm mil n g cn e n olt aa iw gt r e io li nct tnh gt dos dr ic rd et osi ct u r tio p okn oa ra rp cal h tr oee r r pamp odo ra mn ac ts e ei nub ati sl ti c dt ray l f ico nr n sl e r alg tta ol u na k af f h ti ss ul ka n g jup e ncr r p v pcr ri u ue ec r tes sr si e dip dne er een n st tdi jre e ana c pt ai oo ni rn n pa oe ul r bi snn lu ias ckt ht ou en ht aae tl huf n n ap gvu ss seb cl si cc ay h ioe ola f n dl ht h ce uca u rlt rrh er nea n tn td welfare j j au pc nl r c r cu eh u pa rs rr ri ee er idm nm ee ta e n dn ta ia rd en cvvd teis od rri ir r n e j eac c n cosr r e cj dna k rs py j ooe rwn p tak oy c n w na w ol c w h dl lat iad st oja cp oan rp oration j mua n ar r od u um ts si ii dn e eis dra ir rt e eiv c ce r r f ofic r tae sutr k co hc rh opu lo c r inao gtir sop n co r oa c u io r lr tn e n c u curr rn ent factory inc dec executive director otsuka chemical co ltd jan executive director otsuka medical devices co ltd current mar outside director kenedix inc jul executive director otsuka holdings co ltd feb president representative director otsuka pharmaceutical mar senior managing director otsuka holdings co ltd current mar outside director otsuka holdings co ltd current jun executive deputy president executive director otsuka co ltd holdings co ltd mar chairman representative director otsuka pharmaceutical jun representative director otsuka pharmaceutical factory inc co ltd current vice chairman representative director otsuka holdings co ltd mar executive director otsuka pharmaceutical co ltd current chairman otsuka pharmaceutical factory inc current chairman representative director otsuka holdings co ltd current outside directors audit supervisory board members mu ak ko ino tah ku aic gh ii toa bd eanobu e cx fe ocutive director e b mx u ae nic nu aet gi ev p er nir te foct lio executive director mayo bz ao h suir go whi ra mita standing audit outside audit outside director supervisory board supervisory board member member profile profile profile apr joined otsuka pharmaceutical co ltd apr joined tobishima corporation apr senior managing director representative director shinko apr joined baxter limited sep joined otsuka pharmaceutical co ltd foods co ltd otsuka foods co ltd profile profile profile sep pr r j v v po hi ii et c ci r pe e eu c mk p ptd ro tr r e em r ch eet io ds uf nu l e e td ttk n n ih ci n toe g lp c ds csh uo ica r r oke err op c c l ho oa r tlac r r dot e ole du f f f nt ai ic h gn ca e sa cl n occc c uooo e nr p ill tt gr dd c c eo e f pu n rt ti nn mcg ee nd te p oa c tr c st um u ke ann tt g j muu l ag r f c c p v p ci h hio eon ca ora e p r rn pl c ct rr ae ea lc c td e eie rdu u ie sefp ni ii oc ca n ta tr st rl ln uec fc kae e p acn pt n l ro ra vif bc c il tneo ei ca u f lona imrt id tgi edv dii eo b npn u oa w r io n ot es se tu sn k u ta k ao tp h pt usa hkur aam k r c ae cu et uic tia cl l j n ju uol l v e f e c p c eox x r xh oee e eo e sc c cd im u u ud lst te tii icc dnv v va e e eo tl ad dh nle e io rdtp p eld cu u r tnt e oy g p r p p r er r oce e tes si nd u e e kaln n v h e n n ld ir nwr r e ge e c op p sto r r cte e rs os u oe e k n n lst u tc dt khi v v aee e c hici er r ae e mlc c c co ar r l h l ott ds ldu u ik k na g j dap e en c cr j u e q e efi ac nun j n u iie ot ard rgto ir ier neg dgo vce r n idg oira rc ren ha cl n tt nd odt l vea r ev yn msl tse moey onc erj u ga nr h ap ti na e bie n ass l ntt ahc ke nc ioc na lu e grr e li bt jt ude ps ia nc n ero g ss sa e nl uct u nsd rt ta n e hl e e w c lo j tm hp c la tn ru e b shi j j ap n n ar j c c co f hpi rn oe eee c mr l atd tot crd io r n c g lt n e h u ook e f la r n f dm c ic g neah grmt ie ib n cn h f ooc c r e ml n lh tt e ti rl n noin ostg wys u k tc oeao c u h dl ket e ad p ca c hrn eo ml w h e n co al td lt cnu g otk ss u c kc la toh e lti dc al f juec c nbt j j l v co l oucci n e se e ip ld tr e dec ah e id lu u co e uo di nt r ta e u nwtd ts iut l ul c c pch eo ae rr p vp iioo sta ohr la rm ymti ao batn os nu aa r g dn e mmw e e n md cl eo ri e l st uu k ac ch u rr et lo dnh nm ga tsu apr v c v oi io tc c se e u klp p atr rde e ps hd ae e rn n mt cei ir r ue e tc c ict alr r co f h h le e dt fa inx nce ep r ce cn ot u tt insu gk da eh po al rd tmin eg ns jan cn e od n io lp r r dviv ica ete p l reim sidit ee nd presidents office otsuka holdings j ju un n v c ci hc ae rlc mth aa nir ana dn ra en pd r er se ep nr te te ivn et dti iv ree c toir c oto tsr u ko cu hk ea fo ico ad l c ltd mar ouit ts su idb eis h di ru ecf tj r tg sa un k ha dey ge sc cur oit ie ls dc c u l rt rd e nt j du en c c exo e epr cp uo r ttr im va et ee dn irf ef cic tte osur r k cai rpoct oldo rir g ef ct mc nlr tp isdo rr aa tt ie nf aa cn cc oe u n ta inc gc au nn dt tg j ou cn p ohu uat trs smi id dae ec deuu irt ed ccit ta l rc nu ip p e l ptr odv ni pr ay r kb io na gr em vee lm opb mer e tt cu ok ltd ar r e ex xe ec cu ut ti iv e di ir ec ct r c co forp ora tst ue kf han oc lde n gst cu oka h lto dl cug rs r ec ltd mar e e hx x ote es lc u c du uk int tai gv v p se e h cd da ori ir rm e e c ca lt tc der r u tf b cii c u un ra l r n n ecc e noe pn l otd r tb f ou c ls u ioin r mes ns np ao grt ef moli eo n oan tsa ug ke ent j ju un n v cti oac e n lc tnh dga ir ua dn ss uu pk ea r vf io od rys bc oo r dl md ember otsuka holdings mar e cx ot es ru c puk ota riv ac e te h v e sim c ee ri v c p ia crl ee c dio e e p n al tt rd c er np r oat te su f kin hn oc le n ga sc cco ou n lt tin dg mar cu od l u cp ue rrr ev nis ry board member otsuka pharmaceutical nov president representative director otsuka foods co ltd mar standing audit supervisory board member otsuka holdings jun executive director otsuka holdings co ltd current co ltd current mar chairman otsuka foods co ltd mar cu ud rri et n supervisory board member otsuka chemical co ltd mar executive director otsuka foods co ltd current yoko kazuo masayuki noriko makoto wachi takahashi kobayashi tojo inoue outside audit outside audit executive director executive director executive director supervisory board supervisory board member member profile profile profile profile profile oct joined taiho pharmaceutical co ltd apr joined goldman sachs japan corporation apr joined otsuka pharmaceutical co ltd apr registered attorney law daiichi tokyo bar association apr joined ebaraudylite co ltd jcu corporation aug president taiho pharma usa inc taiho oncology inc aug joined shearson lehman brothers holdings inc jun vice president general manager diagnostic division otsuka joined kajitani law offices current mar executive director strategic planning ra institute co ltd sep executive director taiho pharmaceutical co ltd jul engagement manager mckinsey company japan office pharmaceutical co ltd jun corporate auditor nichias corporation nov executive director general manager system division ap p pr r r p p c e cr r xo e e ci ud rl mte e idn n v et n dc n n u tir ad r er cc r tn oe oe po r ne aso ce oht n ls otu gk pt ya hi v ae ia nr md ci e ar er cui c uc sa ro ra e ri nn tc na cih pharmaceutical j f au eu pn bg r c e px ri er ee sn cc u da lt tgo et id nvir n e gi n ad nd ie r di el r e cc ctca etp ori r ocl toj u sa r ukp p kaa n r ei e mn eie c rl e icc v l ae l r e ip nvpo cm cr ea e st n co tn ls tu dk holdings j au pn rr b c e n exe xu uo e en c ci ri u uler ct tt edv v vs u e e ic de civ ip r ri les er sie c c bts tn oi ud r rs e nen pt x et hs e au scd rk u mde tp avvpu vieh st tay v e r nig c lee l cn pc te e r ser u ua st kil c ea pnla ht n g rg mee anr c eo erf u lp imh caa lr nm ca oa g c e e r lu tot di fc al jua nr c oo uu tt ss ii l dd ee da iu c ru ed crit r te n r nu ip che ir av sis cor oy r pb oo ra ar td io n e cm urb er n tsuka holdings mc e k e c u x x u se e en suc c nk tu un vu ik rs ov vu e e e ns r dca io es r r fe e rc c ac l oi la cr r mt h e h c ais ne h e ai ai en ed g fc r e e mf f la et th h nioe e tn oi sn ff oa fo cfr f em ic g e cet io ra ce nn ln ed ky ts hs st ere u nnte kt g e uryi sv n oi casi lf oo f c c e l nc dtti rhr oc e e mar executive director otsuka holdings co ltd current aug executive director ceo pharmavite llc mar managing director nutraceuticals business otsuka may executive director head area franchise circle k sunkus jan president representative director otsuka medical devices pharmaceutical co ltd co ltd co ltd current sep executive director daiya foods inc may executive director head information systems division circle k may executive director otsuka america inc mar senior managing director nutraceuticals business otsuka sunkus co ltd mu ag r c exh ea ci urm tiva en p irh ea cr tm ora v oit te ul kl ac holdings co ltd current oct p ch ha ar im rma ac neu nic aa rdl c obo e l l st ad mar cou ld te u cud rit n ts upervisory board member otsuka holdings mar executive deputy president executive director otsuka pharmaceutical co ltd mar president representative director otsuka pharmaceutical co ltd current executive director otsuka holdings co ltd current otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report messages outside directors enhancement expansion businesses critical high expectations otsukas contributions life stronger governance year lifespan preventive medicine year members board directors asked evaluate boards chairman ensured board meetings forum members effectiveness give detailed account roles board discuss matters freely fosters meaningful discussions furthermore members robust assessment medical doctor expected contribute believe appointment new president otsuka pharmaceutical opinions based broad expertise many years involvement clinical strengthened governance framework medicine public health healthcare administration strived live china longheld belief herbal medicines proper expectations diet share similar principles today widely accepted everywhere healthcare essential aspect social infrastructure everybody needs balanced diet basis good health otsuka groups strong footing healthcare given healthcare critical life level quality must food nutrition may attributable belief philosophy otsuka paramount requirements demands also significant healthcare good work respect safety security consumers appreciate costs rise year year therefore essential make effective use approaching age common people live finite resources otsukas pharmaceutical business entails efficient preventive medicine play vital role many companies creation drugs medical devices diagnostic agents turn supports able offer solutions treatment prevention solutions indeed many efficient provision patients nutraceutical business means creating businesses give unable make quick profit otsuka group products help people maintain improve wellbeing going forward ready long haul even product sell well initially otsuka otsuka holdings must continue offer value society areas patience determination go distance hope otsuka continue vein benefit society yukio matsutani outside director yoshihisa aoki outside director meeting expectations stakeholders sharing otsukas unique corporate story worldwide based sincerity build broad stakeholder loyalty provision information prior board meetings enhanced including first impression otsuka group uniqueness operating many timing important information shared individual briefings explanations years pharmaceuticals healthcare well food nutrition expect provided regarding status group companies operational data sustain operations long future indeed centenary approaching feel one strengths otsukas corporate culture embodiment look forward seeing otsuka advances second century integrity humility goes long way earning trust customers see role bridge company management analysts business partners otsuka committed providing consumers patients shareholders investors outside director hope support otsukas solid value generates revenues profits development pointing opportunities management diligently raising results pharmaceutical business excellent medium concerns necessary tolongterm perspective look drug pipeline indicates room enterprise comprises broad range businesses otsuka complacency also vital otsuka becomes truly global company believe important identify common threads unite key evolves next stage rather simply operating collection companies effectively convey story shareholders investment adopting approach otsuka develop clear roadmap future market also customers consumers employees otsuka able convey story passion sure acquire many longterm fans ko sekiguchi outside director mayo mita outside director otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsuka group global conflict interest policy addition internal audit department otsuka group recognizes conflicts interest direct authority president established compliance group individual employees matter could conducts regular audits based internal audit rules impact integrity organization one verify operations executed appropriately legal compliance cornerstone business activities otsuka group maintains high ethical standards conducts great bearing groups future based thinking efficiently regard assets business business activities integrity order secure trust stakeholders achieve sustainable growth formulated otsuka group global conflict interest general otsuka holdings affiliated companies policy prevent conflicts working instill department submits audit reports president policy global level directors audit supervisory board members cases finds need improvements department universal compliance training participation rate otsuka group global privacy policy issues improvement advisories follows check recent years many countries enacted privacy implementation status measures ascertain protection legislation european unions general execution duties suitably improved approach otsuka group global anticorruption policy data protection regulation gdpr implemented may addition department shares information audit established otsuka group global code otsuka group global anticorruption policy embodies otsuka group working strengthen privacy protection supervisory board members accounting auditor business ethics openly convey information reiterates steadfast commitment conducting addition formulating otsuka group global privacy coordinates unified stance stance related initiatives website business integrity compliance relevant policy define stance guiding principles privacy form message president otsuka holdings anticorruption laws policy outlines prevent protection establish related rules review management whistleblowing hotline furthermore formulated otsuka group global detect deter violations anticorruption laws systems accordance laws regulations related internal whistleblowing hotline anticorruption policy expresses stance sets forth global minimum standards regarding privacy protection country otsuka holdings domestic overseas group corruption sites worldwide otsuka group global prevention corruption applies worldwide companies established internal whistleblowing conflict interest policy aimed maintaining objectivity business operations training system hotline within group offices attorney business otsuka group global privacy policy otsuka group conducts universal compliance training accessed safely anonymously defines stance guiding principles privacy least annually based content global hotline work ensure improper acts protection policies form basis conducting code business ethics global anticorruption policy including acts bribery well violations policies business high ethical standards global conflict interest policy employees laws regulations quickly uncovered subsidiaries attend training materials available corrected rules accepting reports extend beyond full japanese english chinese indonesian furthermore time employees include contract dispatched part guiding principles synopsis implementation status training regularly reported time employees information whistleblowers board directors otsuka holdings reports strictly managed order prevent adhering anticorruption respect uphold letter spirit applicable anticorruption laws domestic laws policies foreign negative repercussions information operational monitoring status internal whistleblowing hotline major group never give accept directly indirectly anything value eg bribes kickbacks gifts holding company whose role maximize otsuka companies regularly reported meetings board prohibiting bribery entertainment improperly influence person obtain retain financial business groups corporate value otsuka holdings established directors otsuka holdings advantage system ensure appropriate business operations working thirdparty require thirdparty suppliers ensure compliance policy well relevant anticorruption perspective group whole established b external inquiries external suppliers laws regulations system facilitating cooperation otsuka group whistleblowing hotline perform due diligence obtain informed assessment nature extent potential system affiliated companies report otsuka otsuka holdings major group companies conducting due diligence corruption risks associated retention thirdparty suppliers working otsukas behalf holdings necessary regarding items specified established whistleblowing hotline accepts inquiries affiliated company management regulations obtain opinions external stakeholders general customers refusing make facilitating payments make facilitating payments kind approval relevant important items furthermore certain channels hotline also accept examples overseas initiatives include appointment anonymous consultations reports provide annual training regarding policy anticorruption laws incorporating providing training compliance officers group company asia otsukas global compliance program holding regular meetings sharing status due diligence keep complete books records reasonable detail accurately fairly documenting progress country director charge group company established due diligence policy recording reflecting transactions including expenses disbursements receipts disposition assets compliance also visits companies gather information conducts due diligence new business partners offer suggestions improvements may made needed evaluate corruptionrelated risk monitoring maintain internal controls focused detecting deterring improper business practices promptly report instances activities may violate appear violate policy internal reporting concerns legalcompliance department tolerate form retaliation anyone making good faith report potential violation otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report excerpt otsuka group global anticorruption policy risk management working thirdparty suppliers anticorruption due diligence conducting business according rigorous legal ethical due diligence includes investigations thirdparty suppliers otsuka group carries risk management supervision top management based recognition pursuing professional standards require standards third background reputation financial records codes conduct management efficiency controlling risks inherent business activities important enhancing corporate value party suppliers perform services otsukas behalf otsuka training business conduct well written agreements held liable actions third parties act intermediaries monitoring controls following circumstances typically necessitate behalf otsuka conduct business dealings anticorruption due diligence engaging services third prohibitions apply employees apply equally individuals party supplier b entering joint venture another entity entities acting behalf accordingly commitment anti c merging acquiring another entity perform due diligence risk management system fully equipped prepared bcm standpoint corruption activities includes use special care business dealings proceeding proposed business transaction establishing risk management system otsuka collaboration mainly otsuka thirdparty suppliers intermediaries continuously evaluating thirdparty suppliers adherence relevant group put place risk management policy pharmaceutical otsuka pharmaceutical factory taiho anticorruption laws outset relationship thirdparty suppliers set risk management committee committee pharmaceutical otsuka warehouse otsuka group clearly articulate effectively communicate policy conduct risktailored riskbased due diligence due diligence comprises president representative director making every effort strengthen countermeasures corruption well commitment transparent responsible process must factbased inquiry closely tailored specific chair director charge administration vice systems group whole effectively business conduct expect thirdparty suppliers share uphold business operations thirdparty suppliers define proper chair well information disclosure officer continue business activities thereby ensure stable dedication level due diligence thirdparty supplier depending key internal control officer leveraging controls operated product supply even times disaster major reevaluate business relationship thirdparty suppliers risk factors eg industry geographic location reputation beneficial risk management department risk management group companies jointly conducted desktop simulation ownership professional capability experience financial standing fail ensure compliance relevant laws regulations committee assesses comprehensively manages risks drill scenario earthquake epicenter credibility thirdparty supplier history third policy upon indication misconduct duty could jeopardize sustainable enhancement directly tokyo jointly conducted party suppliers compliance applicable anticorruption laws report misconduct internal legalcompliance department group value another desktop simulation drill time scenario regulations scope services performed typhoon passing directly western japan intended onetime event due diligence considered responsibilities drills provided opportunities testing cooperation systems ongoing process must periodically reexamine relationship risk management committee closetorealistic conditions focus ensuring thirdparty suppliers frequency reexamination may risk management committee examines group stable product supply depend level risk presented party well context risk management policies coordinates engaged companies departments issues instructions risk management training risk manifests reports risk information risk management training held annually directors board directors issues instructions companies audit supervisory board members executive officers promotes compliance department heads major group companies training includes simulation drills lectures outside experts tax compliance approach involves discussions reviews subject otsuka group individually assesses risks domestic overseas risk referencing serious incidents otsuka group complies otsuka group global code business ethics groups tax policy countryspecific laws businesses risk management officers responsible matters topics include initial response regulations tax treaties well international taxation rules engage transactions designed evade analyzing evaluating risk formulating coordination information among group executing action plans organization meet crisis occurs measures ensure business continuity payment taxes carries appropriate filing payment taxes country endeavor appropriately disclose objectives targets also periodically implement corporate social responsibility information ensure degree transparency trust dealing tax authorities country complexity tax employee training reference events could pose oversight increases businesses become global continuously updating information engaging prior consultations risk within organization training related topics information security tax experts necessary appropriately responding order minimize tax risk corruption prevention protection human otsuka group established otsuka group global rights based otsuka group global code business security policy basic policy information security ethics another part approach furthermore endeavor ensure shared awareness policy correspondence tax authorities relevant authorities also necessary make use regularly hold drills prepare unexpected events group companies including overseas subsidiaries otsuka group engages constructive relationships advance pricing agreements apas obtain aheadoftime disasters striving raise level constantly improve comprehensive security across group set tax authorities countriesregions consensus tax authorities business continuity planning management otsuka group information security committee examine operates continue improve reliability tax otsuka group business continuity plans bcps specific measures share uptodate information data establish systems provide promptly governance place ensure group continues operate regard information security based policy work maintain improve taxrelated governance effectively possible order maintain stable order counter risk cyberattacks otsuka group transfer pricing policy recognizing contributes enhancement supply products even largescale earthquakes employs number measures arranging system otsuka group calculates transfer prices based corporate value end active involvement disasters strike security audits external specialists diagnosing website perspective business continuity management vulnerabilities conducting drills related targeted email oecd guidelines created prevention cfo strengthening cooperation bcm otsuka holdings group companies attacks monitoring posts social media group double taxation fair application transfer price tax departments operating companies well securing cooperating construct groupwide business continuity also conducts regular emergency drills focus system well countrys transfer price tax system training capable human resources thereby maintaining framework august acquired iso core systems construct data addition built makes efforts ensure proper transactions appropriate system enhances tax compliance certification production stable supply capabilities responding cybersecurity emergency related parties recent years oecd issued reduces tax risks furthermore established pharmaceutical products beverages foods situations including establishment computer since gradually expanded scope certification security incident response team csirt preempts action plan base erosion profit shifting beps reporting obligations board directors acquired additional certification stable supply occurrence damage cyberattacks targeting multinational corporations engage international audit supervisory committee regarding intravenous solutions april stable personal information trade secrets held respective transactions lead double nontaxation mentioned policies processes well ongoing supply anticancer agents may acquisition group companies properly execute obligations make submissions implementation maintenance iso certification demonstrates organization otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report financial nonfinancial highlights visit otsuka holdings website major csr data httpswwwotsukacomencsrhdactivity downloadmajorcsrdataenpdf revenue overseas revenue ratio business profit business profit margin number employees number female managers female manager ratio billion billion plan plan revenue left overseas revenue ratio right business profit left business profit margin right outside japan japan number female managers left female manager ratio right scope companies including otsuka holdings subsidiaries scope fiscal six major companies otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka warehouse otsuka chemical otsuka foods fiscal nine companies six companies listed plus otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite profit attributable owners company return equity attributable owners company roe rd expenses pharmaceutical business rd ratio number employees taking parental leave total co emissions billion billion thousand tonsco tons million japan indonesia india south korea north america china europe others plan plan profit attributable owners company left rd expenses pharmaceutical business left female male total co emissions left co emissions per sales right return equity attributable owners company roe right rd ratio right scope fiscal six major companies otsuka pharmaceutical otsuka pharmaceutical scope production sites consolidated otsuka group note excluding impairment losses factory taiho pharmaceutical otsuka warehouse otsuka chemical otsuka foods fiscal nine companies six companies listed plus otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite total assets ratio equity attributable owners company total assets annual dividend per share dividend payout ratio water usage water use efficiency total waste volume billion thousand million tons tons material recycling composting conversion tons feed reuse etc tons p fuo ew l e cor ng en sr ioa ntion heat use tons landfills tons simple incineration others total waste volume tons plan scope production sites consolidated otsuka group total assets left annual dividend per share left outside japan left japan left water use efficiency right ratio equity attributable owners company total assets right dividend payout ratio right scope production sites consolidated otsuka group otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report main data effect fiscal ended december otsuka adopted international financial reporting standards ifrs information fiscal ended december also presented line ifrs jgaap ifrs ifrs item results revenue billion us million operations selling general administrative billion us million expenses business profit rd expenses billion us million ratio business profit rd expenses revenue rd expenses billion us million rd ratio business profit billion us million business profit margin operating profit billion us million operating profit margin profit attributable owners company billion us million financial total assets billion us million position total equity billion us million ratio equity attributable owners company total assets roe cash flows net cash flows operating activities billion us million net cash flows used investing billion us million activities free cash flows billion us million dividends annual dividend per share us dividend payout ratio common number shares outstanding yearend thousand thousand stock shares shares stock price stock price yearend us number total persons employees japan persons outside japan persons line items based ifrs sga expenses jgaap presented total expenses less rd expenses company believes information useful investors comparing companys financial results jgaap ifrs excluding impairment losses business profit revenue cost sales selling general administrative expenses share profit associates rd expenses due change consolidated fiscal year fiscal ended december transitional period covering nine months april december december company finalized provisional accounting treatments business combinations reflected presentation figures year ended december calculated us number employees companies including otsuka holdings co ltd subsidiaries december otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report corporate information global network corporate profile company organization december april company otsuka holdings co ltd name established july capital billion head office kandatsukasamachi chiyodaku tokyo japan tokyo shinagawa grand central tower konan headquarters minatoku tokyo japan telephone number consolidated employees business control management related activities description respect companys subsidiaries affiliates operating pharmaceutical nutraceutical consumer product businesses europe companies north japan america otsuka operates asia companies middle east companies countriesregions south companies central america oceania companies companies otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report gniteem sredloherahs srotcerid fo draob namriahc tnediserp group structure overview main operating companies otsuka group corporate philosophy internal control department internal audit department nutraceutical business global strategy overview planning headquarters otsuka group companies whose origins date back aims contribute health people around world aims corporate planning department two main pillars pharmaceutical business diagnosis treatment diseases nutraceutical business global business support department support maintenance promotion everyday health finance accounting department companys culture summarized words ryukangodo sweat recognize way jissho actualization project office sozosei creativity fostered successive otsuka leaders emphasized employees across group companies countries regions strive create market unique products services tax department nutraceuticals nutritionpharmaceuticals end december otsuka holdings subsidiaries affiliates corporate service department business development department investor relations department organizational structure administration department otsuka holdings president office public relations department sustainability promotion department otsuka pharmaceutical otsuka pharmaceutical taiho pharmaceutical otsuka warehouse otsuka chemical otsuka foods otsuka medical factory devices human resources department human resource planning department planning department legal affairs department statutory auditors board statutory statutory auditors office auditors otsuka pharmaceutical total healthcare company supporting wellbeing whole body co ltd treatment diseases promotion everyday health corporate philosophy otsukapeople creating new products better health worldwide otsuka pharmaceutical operates two core businesses pharmaceutical business provides breakthrough treatments patients around world nutraceutical business helps healthy people maintain good health global network otsuka pharmaceutical original company otsuka group leader iv solutions december factory inc japan years experience field based management vision best partner clinical nutrition otsuka pharmaceutical factory creates innovative products meet variety needs including pharmaceuticals medical devices oral rehydration solutions medical foods otc pharmaceuticals company operates globally focus japan rest asia taiho pharmaceutical pioneer oral anticancer agents japan half century co ltd strive improve human health contribute society enriched smilesthis corporate philosophy taiho pharmaceutical rd driven specialty pharmaceutical company focusing fields oncology allergy immunology urology oncology field particular taiho pharmaceutical recognized one japans leading companies actively expanding global presence consumer healthcare business seeks insights people focuses creating new products better attuned lifestyles otsuka warehouse contributing peoples health worldwide field logistics co ltd since founding otsuka warehouse operated businesses emphasis pharmaceutical food product logistics includes building common distribution platform otsuka groups three core categories pharmaceuticals foods beverages daily necessities recent years otsuka warehouse working extend logistics solutions outside group otsuka chemical creatively giving shape power materials future together customers co ltd materials core operations otsuka chemical aims continuous technological innovation leads creation products enable higher standards living otsuka chemical provides products global markets automotive electrical electronic equipment housing healthcare areas main segments hydrazine business inorganic composite materials business pharmaceutical intermediates active pharmaceutical ingredient api business otsuka foods co ltd creating highvalueadded products offer new dietary lifestyles since otsuka foods operates motto company begins people food begins spirit deliciousness safety peace mind better health heart spirit food shared employees today aging societies among many issues relating health environment demographic change transforming social landscape otsuka foods continue pursue solutions address kind social change creating providing products customers need company contributes people world otsuka medical devices introducing new technologies make otsukas medical devices business unique co ltd otsuka medical devices seeks grow medical devices business operates mainly japan china asian countries core business otsuka group otsuka medical devices achieving growth bringing together groups experience knowhow medical devices order integrate latest technology new devices meet emerging healthcare needsdisclosure otsuka group shareholder information december otsuka group provides overview financial nonfinancial information integrated report visit otsuka holdings website additional information including consolidated financial number shares authorized shares principal shareholders top statements financial results presentations supplementary documents information research development number shares issued shares number shareholding name shareholder shares held number shareholders ratio thousand website investor relations nomura trust banking co ltd otsuka founders shareholding fund trust account httpswwwotsukacomen httpswwwotsukacomenir master trust bank japan ltd trust account stock distribution otsuka estate co ltd treasury shares securities japan trustee services bank ltd trust account companies otsuka group employee shareholding fund corporations awa bank ltd financial institutions japan trustee services bank ltd trust account otsuka asset co ltd japan trustee services bank ltd trust account otsuka groups csr jp morgan chase bank httpswwwotsukacomencsr individuals others overseas number shares held rounded nearest thousand corporations excluding treasury stock held company shares shareholding ratio calculated excluding treasury stock maximumminimum stock price volatility year total shareholders return maximum minimum volatility fiscal fiscal stock price stock price standard deviation comparison topix total return index integrated report cautions regarding forwardlooking statements beginning fiscal edition otsuka holdings combined integrated report summarizes operating financial results annual report csr report single integrated report brings otsuka holdings co ltd subsidiaries fiscal january together financial information nonfinancial information hope december also includes information regarding select deepens stakeholders understanding group aim become material events occurred january date indispensable contributor peoples health worldwide publication report contains forwardlooking statements pertaining stock performance plans projections strategies prospects otsuka group reporting period companies statements based upon current analysis beliefs stock price left trading volume right thousand shares fiscal january december light information available issuing date report note certain information january onward also included actual results may therefore differ due risks uncertainties may affect otsuka group operations scope reporting principle report covers otsuka holdings co ltd medical information subsidiaries otsuka group scope activities data integrated report sake readability unified brand name narrower details noted used product different brand names different countries regions therefore products may available countries guidelines referenced may available different brand names different indications international integrated reporting framework different dosages strengths international integrated reporting council iirc please note information regarding pharmaceutical products gri sustainability reporting standards including products development intended advertising global reporting initiative gri promotional purposes medical advice iso environmental reporting guidelines ministry environment guidance collaborative value creation ministry economy trade industry guidelines otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report significance corporate symbol symbolic representation otsuka groups corporate philosophy corporate symbol adopts initial corporate name motif representing sky large rendered gradations otsuka blue small otsuka red represents focused energy otsuka wellspring tenets offsetting two os otsuka name spelled open friendly typeface corporate symbol conveys otsuka groups energetic commitment human happiness good health